<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Asian Bioeth Rev</journal-id><journal-id journal-id-type="iso-abbrev">Asian Bioeth Rev</journal-id><journal-title-group><journal-title>Asian Bioethics Review</journal-title></journal-title-group><issn pub-type="ppub">1793-8759</issn><issn pub-type="epub">1793-9453</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11785853</article-id><article-id pub-id-type="publisher-id">310</article-id><article-id pub-id-type="doi">10.1007/s41649-024-00310-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8603-6562</contrib-id><name><surname>Kuroda</surname><given-names>Moe</given-names></name><address><email>m.ozawa0320@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Md Koushik</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kuroda</surname><given-names>Kaku</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lane</surname><given-names>Sandra D.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040kfrw16</institution-id><institution-id institution-id-type="GRID">grid.411023.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9159 4457</institution-id><institution>Norton College of Medicine, MPH Program, </institution><institution>SUNY Upstate Medical University, </institution></institution-wrap>Syracuse, NY USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040kfrw16</institution-id><institution-id institution-id-type="GRID">grid.411023.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9159 4457</institution-id><institution>Institute for Global Health and Translational Science, </institution><institution>SUNY Upstate Medical University, </institution></institution-wrap>Syracuse, NY USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0445phv87</institution-id><institution-id institution-id-type="GRID">grid.267346.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 836X</institution-id><institution>Department of General Medicine, </institution><institution>University of Toyama Hospital, </institution></institution-wrap>Toyama, Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/025r5qe02</institution-id><institution-id institution-id-type="GRID">grid.264484.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2189 1568</institution-id><institution>Department of Public Health, Falk College of Sports and Human Dynamics, </institution><institution>Syracuse University, </institution></institution-wrap>Syracuse, NY USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/022kthw22</institution-id><institution-id institution-id-type="GRID">grid.16416.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9174</institution-id><institution>Division of Geriatrics &#x00026; Aging, Department of Medicine, </institution><institution>University of Rochester, </institution></institution-wrap>Rochester, NY USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040kfrw16</institution-id><institution-id institution-id-type="GRID">grid.411023.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9159 4457</institution-id><institution>Department of Obstetrics and Gynecology, </institution><institution>SUNY Upstate Medical University, </institution></institution-wrap>Syracuse, NY USA </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2025</year></pub-date><volume>17</volume><issue>1</issue><fpage>141</fpage><lpage>165</lpage><history><date date-type="received"><day>4</day><month>3</month><year>2024</year></date><date date-type="rev-recd"><day>19</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024, corrected publication 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Japan has been reported as a country with high levels of vaccine hesitancy. However, a lack of comprehensive reviews studying factors for vaccine hesitancy for the COVID-19 vaccines in the Japanese context from the perspective of ethical controversy exists. Using a narrative review method, we reviewed factors associated with vaccine hesitancy to the COVID-19 vaccines and examined issues related to ethical controversy among the Japanese population. Factors associated with vaccine hesitancy include concerns about vaccine safety, suspicion of vaccine inefficacy, mistrust of the government, and low perceived threat. Factors associated with vaccine acceptance include environmental factors, factors related to Japanese cultural values, including collectivism and social norms, and positive attitudes toward information provided by authorities. Unique backgrounds in Japan are historical events such as the anti-HPV vaccine campaigns, the accessible medical system fostering high expectations of zero risk, and cultural factors of caring social norms influencing vaccine acceptance. Ethical controversies arise from preferences and practices at the individual or national level around individual rights versus public health benefits. Healthcare professionals and public health experts should continue dialoguing with the critical mass, practitioners, and policymakers, considering the ethical dilemmas surrounding individual rights and public health benefits. Insights obtained from this study indicate the need to develop tailored strategies to enhance vaccine acceptance while respecting individual autonomy within the Japanese context.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>COVID-19</kwd><kwd>COVID-19 vaccine</kwd><kwd>Vaccine hesitancy</kwd><kwd>Vaccine acceptance</kwd><kwd>Japan</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; National University of Singapore and Springer Nature Singapore Pte Ltd. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><sec id="Sec2"><title>History of Vaccine Hesitancy in Japan</title><p id="Par2">Vaccine hesitancy, which has been defined as &#x0201c;the reluctance or refusal to vaccinate despite the availability of vaccines&#x0201d; by the World Health Organization (WHO), was listed as one of the ten threats to global health by WHO in 2019 (WHO <xref ref-type="bibr" rid="CR88">2019</xref>). Japan has been well-documented for its vaccine hesitancy, as represented by the delayed introduction of multiple vaccinations to the national immunization program compared to other high-income countries (Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>; de Figueiredo et al. <xref ref-type="bibr" rid="CR9">2020</xref>; Wong et al. <xref ref-type="bibr" rid="CR90">2021</xref>).</p><p id="Par3">Several historical adverse events and the subsequent attitude of the government, published in mass media, have been reported to affect vaccine hesitancy in Japan (Nakano <xref ref-type="bibr" rid="CR48">2023</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>). Initially, the national immunization program implemented in 1948 prevailed, contributing to decreasing vaccine-preventable diseases, such as pertussis, measles, etc. (Nakayama <xref ref-type="bibr" rid="CR49">2013</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>). However, there were two deaths after the diphtheria, tetanus-toxoid, and whole cell pertussis (DTwP) vaccine in 1975 (Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>; Nakayama <xref ref-type="bibr" rid="CR49">2013</xref>). Even though the vaccine distribution was resumed after temporary pausing, the vaccination rate dropped (Saitoh <xref ref-type="bibr" rid="CR66">2014</xref>). Also, aseptic meningitis caused by the mumps component of mumps-measles-rubella (MMR) was reported in 1989 (Nakayama <xref ref-type="bibr" rid="CR49">2013</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>). The mass media sensationally reported both events and patients' groups filed several lawsuits against vaccinations (Nakayama <xref ref-type="bibr" rid="CR49">2013</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>). As a result, the Japanese government changed mandatory immunization programs to &#x0201c;effort-duty&#x0201d; vaccination programs in 1994, and other vaccines were assigned to &#x0201c;voluntary vaccinations&#x0201d; (Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>). Consequently, the government became reluctant to add new vaccines to the routine national immunization programs, and the development of domestic vaccines was delayed. For example, as of 2012, some significant vaccines administered in regular vaccines, such as the pneumococcal vaccine for adults and children, the Haemophilus influenzae type b (Hib) vaccine, the mumps vaccine, varicella zoster virus (VZV), the hepatitis B virus (HBV) vaccine, Measles and Rubella (MR) vaccine, Mumps vaccine, the Human Papilloma Virus (HPV) vaccine, Rotavirus vaccines in other high-income countries, were not assigned to a routine but set to a voluntary vaccine in Japan (Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>; Nakano <xref ref-type="bibr" rid="CR48">2023</xref>). As a result, Japan experienced a resurgence of measles and rubella (Ujiie <xref ref-type="bibr" rid="CR86">2019</xref>; Shimizu et al. <xref ref-type="bibr" rid="CR72">2020</xref>; Kitano <xref ref-type="bibr" rid="CR32">2021</xref>). Additionally, the lack of governmental recommendation for the booster of pertussis vaccine in school-age and pregnant women is also a significant example of the negative attitude towards vaccination in Japan(Hiiragi et al. <xref ref-type="bibr" rid="CR20">2021</xref>; National Institute of Infectious Diseases, Center for Epidemiology of Infectious Diseases and Bacteria Division II <xref ref-type="bibr" rid="CR50">2022</xref>).</p><p id="Par4">Another recent important event was the withdrawal of the active recommendation for HPV vaccines in 2013, just two months after the government started a proactive recommendation for HPV vaccines in the same year. Repeated media reports on multiple potential adverse events led the patient groups to sue the government. Even though there was no significant association between these symptoms and the HPV vaccine in 2014, the Japanese government suspended the proactive recommendation of the HPV vaccine (Hanley et al. <xref ref-type="bibr" rid="CR16">2015</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR68">2014</xref>). As a result, data from Hokkaido in Japan showed that the HPV vaccine completion rate dropped from over 70% to 0.6% among eligible girls after the suspension (Hanley et al. <xref ref-type="bibr" rid="CR16">2015</xref>; Simms et al. <xref ref-type="bibr" rid="CR73">2020</xref>; Ujiie et al. <xref ref-type="bibr" rid="CR87">2022</xref>). Another study estimated 5000&#x02013;5700 deaths due to potential cervical cancer among females born between 1994 and 2007 who missed vaccination, brought by a significant drop in HPV vaccine rate from over 70% to less than 1% (Simms et al. <xref ref-type="bibr" rid="CR73">2020</xref>).</p><p id="Par5">With these historical backgrounds and context, it is crucial to document how the concept of &#x0201c;vaccine hesitancy&#x0201d; is understood among the general population and healthcare professionals and how it relates to ethical controversies in the context of Japanese COVID-19.</p></sec><sec id="Sec3"><title>COVID-19 Vaccine Hesitancy and Acceptance in Japan</title><p id="Par6">During the COVID-19 pandemic, vaccine hesitancy became a more significant issue, as shown in Japan's delay in vaccine roll-out and distribution compared to other countries. The roll-out of the COVID-19 vaccines for healthcare professionals in Japan started on February 17, 2021 (Ministry of Health, Labour, and Welfare, Japan <xref ref-type="bibr" rid="CR43">2020</xref>). However, the United States (U.S.), Canada, and the United Kingdom (U.K.) emergently approved the COVID-19 vaccine. They started the vaccine roll-out in December 2020 (Assistant Secretary for Public Affairs <xref ref-type="bibr" rid="CR3">2022</xref>). As of May 2021, only 5.9% of the population had been vaccinated in at least one dose in Japan, whereas the vaccination rate was 56% in the UK, 51% in the U.S., and 49% in Canada (Mathieu et al. <xref ref-type="bibr" rid="CR42">2020</xref>).</p><p id="Par7">However, the vaccination rate increased gradually as Japanese society experienced a drastic surge in the number of positive cases during the summer of 2021, and it reached 80% as of December 2021 (Mathieu et al. <xref ref-type="bibr" rid="CR42">2020</xref>), which was higher than the U.S. and UK at that point.</p></sec><sec id="Sec4"><title>Ethical Controversy of Vaccine Hesitancy</title><p id="Par8">From the ethical perspective of public health, vaccine hesitancy implies a controversy between individual freedom of refusal to be vaccinated and the collective good of the population&#x02019;s health achieved by herd immunity through vaccination (Giubilini <xref ref-type="bibr" rid="CR11">2021</xref>). Giubilini, et al. discussed three theories that counter-argued individual liberty rights of refusal: utilitarianism, contractualism, and the principle of duty of easy rescue (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>). In the theory of utilitarianism, described as &#x0201c;greatest good for the greatest number,&#x0201d; maximizing group benefit, which is building herd immunity in terms of the discussion of vaccination, prioritizes society&#x02019;s benefit over the individual&#x02019;s refusal to be vaccinated, as long as the benefit of being vaccinated surpasses the negative cost of vaccination (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Ochola <xref ref-type="bibr" rid="CR56">2023</xref>; Pavey et al. <xref ref-type="bibr" rid="CR63">2024</xref>). The theory of utilitarianism, which emphasizes an individual&#x02019;s moral obligation to be vaccinated to maximize greater societal welfare and benefits, has been fundamental in the public health policy to widely distribute vaccinations, including coerced vaccine policies (Su et al. <xref ref-type="bibr" rid="CR75">2021</xref>; Ochola <xref ref-type="bibr" rid="CR56">2023</xref>). However, it is crucial to consider the ethical counter-argued concept, the right of individual autonomy, when utilitarianism is applied to public health policymaking (Ochola <xref ref-type="bibr" rid="CR56">2023</xref>). The second theory, contractualism, which addresses how people should act, is based on unwritten principles to which all could agree or would agree under certain ideal circumstances (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Ashford and Mulgan <xref ref-type="bibr" rid="CR2">2018</xref>). Based on this approach, people have a moral obligation to be vaccinated only if vaccination takes a small cost to individuals (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Pavey et al. <xref ref-type="bibr" rid="CR63">2024</xref>). Third, a principle of &#x0201c;duty of easy rescue&#x0201d; also previously reported to support the moral obligation to be vaccinated among the general public, including both adults and children (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Savulescu et al. <xref ref-type="bibr" rid="CR71">2021</xref>). &#x0201c;The duty of easy rescue&#x0201d; claims &#x0201c;when I could do something that entails a small cost to me and a significant benefit to others, I have a moral duty to do it.&#x0201d; Giubilini et al. mentioned that one of the rescue duties is an uncontroversial and responsible approach to justify the collective moral responsibility to achieve herd immunity (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>). On the other hand, the &#x0201c;cost&#x0201d; of rescue differs depending on the individual, such as age difference. For instance, vaccination might be an easy rescue for the older generation. However, it might not be for the younger generation, given their relatively lower risk of being severely affected by COVID-19 (Savulescu <xref ref-type="bibr" rid="CR70">2023</xref>; Cameron et al. <xref ref-type="bibr" rid="CR5">2021</xref>). Those arguments based on utilitarianism, contractualism, and the duty of easy rescue agree to request an individual's moral responsibility for vaccination in society (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>).</p><p id="Par9">As represented by utilitarianism, those theories can justify the vaccine distribution policy over individual rights to refuse, including vaccine allocation and vaccine mandatory policy (Giubilini et al. <xref ref-type="bibr" rid="CR12">2018</xref>; Savulescu et al. <xref ref-type="bibr" rid="CR71">2021</xref>). Nevertheless, policies that mandate vaccines contain the risk of making vaccine-hesitant people more defensive (Qunaibi et al. <xref ref-type="bibr" rid="CR64">2021</xref>; Lin et al. <xref ref-type="bibr" rid="CR38">2020</xref>). Therefore, promoting self-acceptance by providing information about the merits of vaccines and/or nudging towards vaccination is suggested, other than mandate policy by WHO and other experts (World Health Organization <xref ref-type="bibr" rid="CR91">2022</xref>; Nakada et al. <xref ref-type="bibr" rid="CR46">2022</xref>; Lazarus et al. <xref ref-type="bibr" rid="CR37">2021</xref>).</p></sec><sec id="Sec5"><title>Ethical Controversy and Japanese Context</title><p id="Par10">Several previous articles argued that Japan&#x02019;s Confucian cultural values have led to the frequent characterization of Japanese society toward less individualism and more social cohesion, in contrast to the U.S. and other Western countries&#x02019; greater emphasis on individualism (Uehara et al. <xref ref-type="bibr" rid="CR85">2022</xref>; Liu <xref ref-type="bibr" rid="CR39">2018</xref>; Tucker <xref ref-type="bibr" rid="CR84">2022</xref>). Confucian philosophy emphasizes collectivism (Duan et al. <xref ref-type="bibr" rid="CR6">2022</xref>), as in the emphasis on group goals to individual goals and values. In such a context, people might tend to follow theories focusing on the public good. On the other hand, younger generations in Japan are reported to have a greater focus on individualism (Yoshizaki <xref ref-type="bibr" rid="CR95">1997</xref>). This tension between respect for traditions and the contemporary questioning of authority on the part of younger individuals might have also reflected the issue of vaccine hesitancy. Thus, the cohesive Japanese culture that emphasizes collective social norms might have changed somewhat, which could have affected the attitudes toward vaccine uptake among Japanese citizens.</p></sec><sec id="Sec6"><title>Research Gap and Aim</title><p id="Par11">Although studies investigating COVID-19 vaccine hesitancy and the transition to a high vaccination rate exist in Japan, there are no comprehensive reviews studying factors for vaccine hesitancy in the Japanese context of healthcare system and cultural backgrounds from the perspective of ethical controversy, which mainly indicates the conflict between individual autonomy and collective good represented by Confucianism, that is still described by the scholars remaining the strong presence in Japanese values.</p><p id="Par12">The present study aims to investigate factors associated with vaccine hesitancy to the COVID-19 vaccines among the Japanese population, explore researchers&#x02019; perspectives on those factors, and discuss the ethical controversy about COVID-19 vaccine hesitancy in Japan using the narrative review method.</p></sec></sec><sec id="Sec7"><title>Methods</title><sec id="Sec8"><title>Research Design and Researcher&#x02019;s Background</title><p id="Par13">A narrative review is traditionally called a &#x0201c;non-systematic review,&#x0201d; which allows researchers to identify broader research questions, include various studies, and provide a comprehensive summary, with interpretation and critique from different or unusual viewpoints (Gregory and Denniss <xref ref-type="bibr" rid="CR15">2018</xref>; Sukhera <xref ref-type="bibr" rid="CR77">2022</xref>). Exploring historical perspectives of the chosen topic and development of a problem or its management are good examples of what narrative review can cover (Gregory and Denniss <xref ref-type="bibr" rid="CR15">2018</xref>; Green et al. <xref ref-type="bibr" rid="CR14">2006</xref>; Sukhera <xref ref-type="bibr" rid="CR77">2022</xref>; Ferrari <xref ref-type="bibr" rid="CR8">2015</xref>).</p><p id="Par14">The authors selected a narrative review due to the characteristics of the present study&#x02019;s research questions elucidating factors associated with COVID-19 vaccine hesitancy in Japan and experts&#x02019; views about those factors, and the following ethical discussion on the results. For the first research question, to elaborate on what factors have affected vaccine hesitancy for the COVID-19 vaccine in Japan despite the importance of achieving herd immunity by high prevalence of immunization, authors needed to select, analyze and interpret articles using the chronological background of each article (Ferrari <xref ref-type="bibr" rid="CR8">2015</xref>). The second research question is to explore experts&#x02019; perspectives on the ethical controversy of vaccine hesitancy and acceptance of the COVID-19 vaccine in Japan. The characteristics of the research question, which is broad and not a specific clinical question, fit the design of the narrative review (Green et al. <xref ref-type="bibr" rid="CR14">2006</xref>).</p><p id="Par15">Based on a narrative review design, this review followed the narrative methodological framework, which other researchers have widely used (Green et al. <xref ref-type="bibr" rid="CR14">2006</xref>; Ferrari <xref ref-type="bibr" rid="CR8">2015</xref>; Baethge et al. <xref ref-type="bibr" rid="CR4">2019</xref>; Kuipers et al. <xref ref-type="bibr" rid="CR36">2022</xref>). According to the narrative review&#x02019;s framework, we conducted a preliminary literature search, synthesized available literature, and reported the results according to our research questions.</p><p id="Par16">Research questions were determined based on the literature review and the author&#x02019;s background. The first author and the third author (MK and KK) are Japanese family physicians who were studying public health and public health ethics in New York state of the U.S., amid the COVID-19 pandemic, which allowed them to critically review the literature, come up with this research questions, and focus on this ethical controversy. KK is also a family physician in the U.S.. Therefore, the research questions were both dependent on the review of the literature and knowing the Japanese medical system and living and working in the U.S.. The second author (MKA), who is another main author, is a public health professional with experience writing a review article. The last author (SDL) is an anthropologist and public health professional.</p></sec><sec id="Sec9"><title>Literature Search</title><p id="Par17">We conducted literature searches in three databases, including PubMed, Scopus, and CINAHL. We considered articles published in English. In addition, we also used Google Scholar for articles in the Japanese language. We considered the articles that were published from January 1, 2020, to December 31, 2022. Search terms were chosen to address the following research question: &#x0201c;What factors have been affected COVID-19 vaccine hesitancy in Japan?&#x0201d;. The search strategy development included a brief review of the studies related to COVID-19 vaccine hesitancy done in other countries and Japan. Search terms are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Search terms and strings</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Search engine</th><th align="left">Key terms</th></tr></thead><tbody><tr><td align="left" rowspan="3">English peer-reviewed articles</td><td align="left">PubMed</td><td align="left">((("COVID-19" OR "coronavirus" OR "SARS-CoV-2") AND (Vaccine OR Vaccination)) AND (hesitancy OR refusal OR fear OR unwilling)) AND Japan</td></tr><tr><td align="left">Scopus</td><td align="left">((("COVID-19" OR "coronavirus" OR "SARS-CoV-2") AND (Vaccine OR Vaccination)) AND (hesitancy OR refusal OR fear OR unwilling)) AND Japan</td></tr><tr><td align="left">CINAHL (EBISCO)</td><td align="left">((("COVID-19" OR "coronavirus" OR "SARS-CoV-2") AND (Vaccine OR Vaccination)) AND (hesitancy OR refusal OR fear OR unwilling)) AND Japan</td></tr><tr><td align="left">Japanese peer-reviewed articles</td><td align="left">Google Scholar</td><td align="left">((("COVID-19" OR "&#x065b0;&#x0578b;&#x030b3;&#x030ed;&#x030ca;&#x030a6;&#x030a3;&#x030eb;&#x030b9;" OR "SARS-CoV-2") AND "&#x030ef;&#x030af;&#x030c1;&#x030f3;" ) AND "&#x05fcc;&#x0907f; ") AND "&#x065e5;&#x0672c;"</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec10"><title>Selection of Literature</title><p id="Par18">We used the following inclusion and exclusion criteria (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) for the final selection of studies to explore the present study&#x02019;s research questions to identify associated factors and experts&#x02019; opinions about the COVID-19 vaccine hesitancy in Japan and to provide ethical discussion based on the review results. We included original articles / review articles published in peer-reviewed journals to delve into the views of experts stemming from the results quantitatively/qualitatively analyzed about the COVID-19 vaccine hesitancy in Japan critically reviewed (Green et al. <xref ref-type="bibr" rid="CR14">2006</xref>). The selection of studies included a two-stage selection process. At first, titles and abstracts were screened. Secondly, a full-text screening of potentially selected studies was conducted. Full-text screening in English was done independently by two reviewers (MK and MKA), and full-text screening in Japanese was done independently by two reviewers (MK and KK). Articles were considered eligible if they focused on or studied COVID-19 vaccine hesitancy in the Japanese context. The articles excluded by one reviewer were checked by another reviewer. Four authors (MK, MKA, KK, and SDL) discussed the disagreements and reached an agreement. Two authors (MK and KK) are native Japanese speakers. Each inclusion and exclusion was finalized upon detailed discussion and analysis based on the criteria.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Inclusion and exclusion criteria for the selection of studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Inclusion criteria</th><th align="left">Exclusion criteria</th></tr></thead><tbody><tr><td align="left"><p>&#x02022; Papers focusing on the COVID-19 vaccine acceptance/hesitancy</p><p>&#x02022; Papers focusing on or using data from Japan</p><p>&#x02022; Published in English or Japanese</p><p>&#x02022; Published from January 1st, 2020 to December 31st, 2022, and</p><p>&#x02022; Original article and Narrative review and Review articles</p></td><td align="left"><p>&#x02022; Vaccine hesitancy does not involve COVID-19 Study protocol without finding</p><p>&#x02022; Outcome does not involve COVID-19 vaccine uptake or intention, and</p><p>&#x02022; Study protocol, Letter to the editor, Editorial, or Comments</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec11"><title>Review of the Studies</title><p id="Par19">After the final selection, we conducted a full-text review using a priori structured matrix. The priori structured matrix was developed by MK, reviewed by MKA, and supervised and finalized by SDL. The matrix included information from studies on objectives, study approach, study design, data analysis, study period, study population, sample size, and critical findings. After extracting data from all studies, the second reviewer (MKA) checked the data accuracy.</p></sec><sec id="Sec12"><title>Data Collection</title><p id="Par20">Through the search in three databases, 267 articles were identified. After removing duplicates, 212 articles were retained for title and abstract screening. 55 articles were unmet with inclusion criteria. After removing one additional duplicate and 33 articles that did not meet the inclusion criteria, 57 articles were finally included in the content analysis. All processes are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Flow diagram of the article screening process</p></caption><graphic xlink:href="41649_2024_310_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec13"><title>Analysis</title><p id="Par21">We used descriptive statistics such as frequency counts and percentages to give an overview of the studies. Secondly, we used a thematic content analysis approach to critically analyze the factors associated with COVID-19 vaccine hesitancy.</p></sec></sec><sec id="Sec14"><title>Results</title><sec id="Sec15"><title>Study Characteristics</title><p id="Par22">A total of 57 studies explaining vaccine hesitancy in Japan about the COVID-19 vaccines were explored to be analyzed (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Even though inclusion criteria included the publication year from 2020 to 2022, no studies were published in 2020. Most studies are primary research articles (<italic>n</italic>&#x02009;=&#x02009;54/57; 94,7%). The most prevalent study design was cross-sectional (<italic>n</italic>&#x02009;=&#x02009;44/57; 77.2%). In terms of the study population, various populations were identified, although most studies targeted the general population (<italic>n</italic>&#x02009;=&#x02009;24/57; 42.1%), including two articles conducted in specific areas where the emergency declaration was announced at that time. There were articles targeted to specific age groups, such as the young generation (<italic>n</italic>&#x02009;=&#x02009;6/57; 10.5%) and the working-age population (<italic>n</italic>&#x02009;=&#x02009;1/57; 1.8%). 3 articles targeted workers (<italic>n</italic>&#x02009;=&#x02009;3/57; 5.3%). Some articles targeted the healthcare field, including healthcare professionals (<italic>n</italic>&#x02009;=&#x02009;4/57; 7.0%) and medical students (<italic>n</italic>&#x02009;=&#x02009;2/57; 3.5%). Some articles aimed to understand the parental/pregnant/fertile generation, including articles targeting parents (<italic>n</italic>&#x02009;=&#x02009;2/57; 3.5%) and articles targeting pregnant women (<italic>n</italic>&#x02009;=&#x02009;3/57; 5.3%). Patients of the specific were also targeted (<italic>n</italic>&#x02009;=&#x02009;2/57; 3.5%). One article targeted the migrant population (n&#x02009;=&#x02009;1/57; 1.8%). Some articles analyzed the quotes in social media (<italic>n</italic>&#x02009;=&#x02009;2/57; 3.5%) and social media users (<italic>n</italic>&#x02009;=&#x02009;1/57; 1.8%).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Characteristics of included studies (<italic>n</italic>&#x02009;=&#x02009;57)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left"><italic>N</italic></th><th align="left">(%)</th></tr></thead><tbody><tr><td align="left" colspan="3">Year of publication</td></tr><tr><td align="left">&#x000a0;&#x000a0;2020</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">&#x000a0;&#x000a0;2021</td><td align="left">39</td><td align="left">68.4</td></tr><tr><td align="left">&#x000a0;&#x000a0;2022</td><td align="left">18</td><td align="left">31.6</td></tr><tr><td align="left" colspan="3">Study type</td></tr><tr><td align="left">&#x000a0;&#x000a0;Primary research</td><td align="left">54</td><td align="left">94.7</td></tr><tr><td align="left">&#x000a0;&#x000a0;Review</td><td align="left">3</td><td align="left">5.3</td></tr><tr><td align="left" colspan="3">Study approach</td></tr><tr><td align="left" colspan="3">&#x000a0;&#x000a0;Quantitative</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cross-sectional study</td><td align="left">43</td><td align="left">75.4</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cross-sectional study, longitudinal study, and conjoint experimental design</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Randomized conjoint study</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Longitudinal study</td><td align="left">2</td><td align="left">3.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Retrospective cohort study</td><td align="left">3</td><td align="left">5.3</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Prospective cohort study</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Before-and-after trial</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;RCT</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Qualitative</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Review</td><td align="left">3</td><td align="left">5.3</td></tr><tr><td align="left" colspan="3">Study population</td></tr><tr><td align="left">&#x000a0;&#x000a0;General population</td><td align="left">24</td><td align="left">42.1</td></tr><tr><td align="left">&#x000a0;&#x000a0;People who completed all doses of the COVID-19 vaccine</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Young generation</td><td align="left">6</td><td align="left">10.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;Healthcare professionals</td><td align="left">4</td><td align="left">7.0</td></tr><tr><td align="left">&#x000a0;&#x000a0;Medical students</td><td align="left">2</td><td align="left">3.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;Workers</td><td align="left">4</td><td align="left">7.0</td></tr><tr><td align="left">&#x000a0;&#x000a0;Working age (64&#x000a0;years old or younger)</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Parents</td><td align="left">2</td><td align="left">3.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;Pregnant women</td><td align="left">3</td><td align="left">5.3</td></tr><tr><td align="left">&#x000a0;&#x000a0;Specific disease</td><td align="left">2</td><td align="left">3.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;Migrant population</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Users of social media or apps</td><td align="left">1</td><td align="left">1.8</td></tr><tr><td align="left">&#x000a0;&#x000a0;Quotes from social media</td><td align="left">2</td><td align="left">3.5</td></tr><tr><td align="left">&#x000a0;&#x000a0;Review, RCT</td><td align="left">4</td><td align="left">7.0</td></tr></tbody></table><table-wrap-foot><p><italic>RCT</italic> Randomized controlled trial</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec16"><title>Sociodemographic Factors associated with COVID-19 Vaccine Hesitancy in Japan in 2021&#x02013;2022</title><p id="Par23">Various factors associated with vaccine hesitancy were reported targeting the general population. We listed sociodemographic factors below, which have a statistically significant association with vaccine hesitancy reported in the manuscript. Factors were identified from the main text of the articles.</p><p id="Par24">Major demographic factors reported were, younger age&#x000a0;(Yoda and Katsuyama <xref ref-type="bibr" rid="CR92">2021</xref>; Machida et al. <xref ref-type="bibr" rid="CR40">2021a</xref>; Okamoto et al. <xref ref-type="bibr" rid="CR58">2022a</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Kobayashi et al. <xref ref-type="bibr" rid="CR33">2022</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>; Arashiro et al. <xref ref-type="bibr" rid="CR1">2022</xref>; Odani et al. <xref ref-type="bibr" rid="CR57">2022</xref>; Tokiya et al. <xref ref-type="bibr" rid="CR82">2022a</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>; Yoneoka et al. <xref ref-type="bibr" rid="CR94">2022</xref>), female gender (Machida et al. <xref ref-type="bibr" rid="CR40">2021a</xref>; Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>; Okamoto et al. <xref ref-type="bibr" rid="CR58">2022a</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Kobayashi et al. <xref ref-type="bibr" rid="CR33">2022</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>; Odani et al. <xref ref-type="bibr" rid="CR57">2022</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>), low-income level (Machida et al. <xref ref-type="bibr" rid="CR40">2021a</xref>; Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>), low household assets (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>), low financial literacy (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>), non-full-time working or unemployed (Odani et al. <xref ref-type="bibr" rid="CR57">2022</xref>), being pregnant (Odani et al. <xref ref-type="bibr" rid="CR57">2022</xref>), married marital status (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>), living alone (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>), unmarried marital status (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>), occupation outside the health care profession(Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>), occupation outside essential work in the food industry (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>), low educational level (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Tanaka et al. <xref ref-type="bibr" rid="CR81">2023</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>), having no children (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>), and current alcohol use (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>).</p><p id="Par25">Health-related demographics reported were self-reported poor health status (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>), no presence of chronic condition (Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>), presence of comorbidities (diabetes mellitus, psychiatric disorder) (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>)<italic>,</italic> presence of severe psychological distress (Okubo et al. <xref ref-type="bibr" rid="CR61">2021a</xref>), no history of psychological illness (Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>), non-yearly influenza vaccine history (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>), COVID-19 infection/testing history (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>), lack of engagement in COVID-19 preventive measures (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>), absence of underlying diseases or condition (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>), history of a previous vaccine side effect (Kobayashi et al. <xref ref-type="bibr" rid="CR33">2022</xref>), and less concern about health status (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>).</p><p id="Par26">Characteristics of information sources associated with vaccine hesitancy reported were using specific information sources (internet news sites, YouTube, TikTok, Facebook, family members, and scientists and researchers (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>), trust in television (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>), and trust in magazines (Ghaznavi et al. <xref ref-type="bibr" rid="CR10">2022</xref>).</p></sec><sec id="Sec17"><title>Factors for COVID-19 Vaccine Hesitancy and Acceptance in Japan</title><p id="Par27">Four themes of vaccine hesitancy and three themes of vaccine acceptance were identified as the reasons through thematic analysis of the narrative review (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Factors of COVID-19 vaccine hesitancy and acceptance in Japan extracted by thematic analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Themes</th><th align="left">Sub-themes</th></tr></thead><tbody><tr><td align="left" rowspan="8">Vaccine hesitancy</td><td align="left" rowspan="3">Concerns about vaccine safety</td><td align="left">Contextual skepticism for vaccine safety</td></tr><tr><td align="left">High Expectations for Medicine in Japan</td></tr><tr><td align="left">Misinformation</td></tr><tr><td align="left" colspan="2">Suspicion of vaccine inefficacy</td></tr><tr><td align="left" colspan="2">Mistrust of government</td></tr><tr><td align="left" rowspan="3">Low perceived threat</td><td align="left">Low susceptibility made by confidence in personal health</td></tr><tr><td align="left">Low perceived severity</td></tr><tr><td align="left">Lack of fear of getting infected</td></tr><tr><td align="left" rowspan="7">Vaccine acceptance</td><td align="left" rowspan="3">Environmental backgrounds</td><td align="left">Gradual acceptance over time</td></tr><tr><td align="left">Increased access to vaccination</td></tr><tr><td align="left">Fear of infection overwhelming concerns of safety and efficacy</td></tr><tr><td align="left" rowspan="3">Factors related to Japanese cultural values</td><td align="left">Ethical motivation is driven by the responsibility to protect others</td></tr><tr><td align="left">Culture of keeping pace with others</td></tr><tr><td align="left">Fear of stigma when being infected</td></tr><tr><td align="left" colspan="2">Positive attitudes toward information provided by authorities</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec18"><title>Factors of COVID-19 Vaccine Hesitancy in Japan</title><sec id="Sec19"><title>Theme 1. Concerns About Vaccine safety</title><sec id="FPar1"><title>Sub-Theme 1.1: Contextual Skepticism for Vaccine Safety</title><p id="Par28">One of the important events related to contextual skepticism was the excessive emotional announcement by the media about the potential side effects after the HPV vaccine uptake among young females and the governmental decision of the suspension the regular occlusion of the HPV vaccine (Niu et al. <xref ref-type="bibr" rid="CR53">2022b</xref>; Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>; Yoda and Katsuyama <xref ref-type="bibr" rid="CR92">2021</xref>; Ishimaru et al. <xref ref-type="bibr" rid="CR25">2021</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Miyachi et al. <xref ref-type="bibr" rid="CR44">2022</xref>; Kajiwara et al. <xref ref-type="bibr" rid="CR27">2022</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>). Not only the HPV vaccine, the influenza vaccine (Yoda and Katsuyama <xref ref-type="bibr" rid="CR92">2021</xref>), and the MMR vaccine (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>) have also affected Japanese historical vaccine hesitancy, as is well known&#x000a0;(Khan et al. <xref ref-type="bibr" rid="CR30">2022</xref>). The available evidence suggests that the memory of these events among the general public might have remained, contributing to an overarching skepticism toward general vaccine safety, even with the COVID-19 vaccines (Niu et al. <xref ref-type="bibr" rid="CR53">2022b</xref>; Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>; Yoda and Katsuyama <xref ref-type="bibr" rid="CR92">2021</xref>; Ishimaru et al. <xref ref-type="bibr" rid="CR25">2021</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Miyachi et al. <xref ref-type="bibr" rid="CR44">2022</xref>; Kajiwara et al. <xref ref-type="bibr" rid="CR27">2022</xref>; Yoda et al. <xref ref-type="bibr" rid="CR93">2022</xref>). Also, another factor related to contextual skepticism could be rooted in Japan's lack of primary care doctors. Japanese citizens have easy access to specialists and large hospitals instead of having primary care doctors. Moreover, the opportunities to visit clinics in person were limited amid the pandemic, which could make people have lower confidence in healthcare provider&#x02019;s recommendations (Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>). This limited access to primary care physicians might hamper the provision of reliable, personalized information to assuage these safety concerns (Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>; Kimura et al. <xref ref-type="bibr" rid="CR31">2022</xref>).</p></sec><sec id="FPar2"><title>Sub-Theme 1.2: High Expectations for Medicine in Japan</title><p id="Par29">One study indicated the tendency of Japanese citizens to expect higher effectiveness and safety of the vaccine than the U.S., which could make people less tolerant to adverse events by the vaccines (Hara et al. <xref ref-type="bibr" rid="CR17">2021</xref>). Another study showed that Japanese adults prefer domestically developed vaccines and clinical trials for the COVID-19 vaccine compared to internationally developed vaccines and clinical trials (Kawata and Nakabayashi <xref ref-type="bibr" rid="CR28">2021</xref>).</p></sec><sec id="FPar3"><title>Sub-Theme 1.3: Misinformation</title><p id="Par30">Misinformation, especially through social media and TV, influenced concerns about vaccine safety (Miyachi et al. <xref ref-type="bibr" rid="CR44">2022</xref>; Okubo and Yoshioka <xref ref-type="bibr" rid="CR60">2021</xref>; Kimura et al. <xref ref-type="bibr" rid="CR31">2022</xref>; Tokiya et al. <xref ref-type="bibr" rid="CR82">2022a</xref>; Ferawati et al. <xref ref-type="bibr" rid="CR7">2022</xref>; Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Yoneoka et al. <xref ref-type="bibr" rid="CR94">2022</xref>). False information such as &#x0201c;COVID-19 vaccine could damage reproductive function&#x0201d;, &#x0201c;the vaccine could make people infected with COVID-19&#x0201d; etc. have been reported (Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>; Harada and Watanabe <xref ref-type="bibr" rid="CR18">2021</xref>). Another example was the over-announcement about side effects in other countries. Overemphasized media reports about the side reactions in the U.K. and U.S. in December 2020, while the clinical trials had been still processed in Japan, might have affected vaccine hesitancy in Japan (Ishimaru et al. <xref ref-type="bibr" rid="CR25">2021</xref>). One of the characteristics of misinformation in Japan is that over-announcement of side effects by the media is more popular, while conspiracy is less popular (Takahashi et al. <xref ref-type="bibr" rid="CR79">2022a</xref>; Tokiya et al. <xref ref-type="bibr" rid="CR83">2022b</xref>). Misinformation has been widespread in Japan's anti-HPV and anti-MMR vaccine campaigns (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>).</p></sec></sec><sec id="Sec20"><title>Theme 2. Suspicion of Vaccine Inefficacy</title><p id="Par31">The rapid development and approval of COVID-19 vaccines, while a remarkable scientific achievement, made some populations anxious about the efficacy in addition to the uncertainty of safety. These concerns, revolving around the perceived speed of development, have led some to question the thoroughness of the clinical trials and the long-term effects of the vaccines (Tanaka et al. <xref ref-type="bibr" rid="CR81">2023</xref>; Sugawara et al. <xref ref-type="bibr" rid="CR76">2021</xref>).</p></sec><sec id="Sec21"><title>Theme 3. Mistrust of Government</title><p id="Par32">Some studies mentioned a lower trust in the Japanese government's actions and decisions as an essential factor affecting vaccine hesitancy. Mistrust of the government could jeopardize both vaccine safety and efficacy (Hosokawa et al. <xref ref-type="bibr" rid="CR24">2022</xref>; Kobayashi et al. <xref ref-type="bibr" rid="CR33">2022</xref>; Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>; Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>; Okubo and Yoshioka <xref ref-type="bibr" rid="CR60">2021</xref>; Tanaka et al. <xref ref-type="bibr" rid="CR81">2023</xref>). One study cited that the level of public trust in Japan's government is lower than in other countries (Kobayashi et al. <xref ref-type="bibr" rid="CR33">2022</xref>).</p></sec><sec id="Sec22"><title>Theme 4. Low Perceived Threat</title><sec id="FPar4"><title>Sub-Theme 4.1: Low Susceptibility made by Confidence in Personal Health</title><p id="Par33">Confidence in personal health diminished the susceptibility to COVID-19. This tendency is more popular among the young generation (Khan et al. <xref ref-type="bibr" rid="CR29">2021</xref>, <xref ref-type="bibr" rid="CR30">2022</xref>) or those with no particular medical histories (Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>). Consequently, these individuals perceive a lower urgency to vaccinate, considering themselves less susceptible to severe infection and to be contagious to others.</p></sec><sec id="FPar5"><title>Sub-Theme 4.2: Low Perceived Severity</title><p id="Par34">Low perceived severity was one of the essential psychological factors contributing vaccine hesitancy (Machida et al. <xref ref-type="bibr" rid="CR40">2021a</xref>, <xref ref-type="bibr" rid="CR41">b</xref>; Miyachi et al. <xref ref-type="bibr" rid="CR44">2022</xref>; Okamoto et al. <xref ref-type="bibr" rid="CR58">2022a</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR79">2022a</xref>). Low perceived severity can become a reason for vaccine hesitancy among the young generation, considering the older generation is at higher risk of becoming severely affected by COVID-19 infection, which makes the younger generation challenging to be willing to receive vaccines from the viewpoint of utilitarianism (Okamoto et al. <xref ref-type="bibr" rid="CR58">2022a</xref>).</p></sec><sec id="FPar6"><title>Sub-Theme 4.3: Lack of Fear of Getting Infected</title><p id="Par35">Also, a lack of concern (Okubo and Yoshioka <xref ref-type="bibr" rid="CR60">2021</xref>), and a lack of fear of getting infected or being infected by others, were reported to reduce the motivation toward vaccine uptake (Arashiro et al. <xref ref-type="bibr" rid="CR1">2022</xref>). Some studies reported that people with myopic views among the people were associated with vaccine hesitancy because those people don&#x02019;t expect the future direction (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Khan et al. <xref ref-type="bibr" rid="CR29">2021</xref>, <xref ref-type="bibr" rid="CR30">2022</xref>).</p></sec></sec></sec><sec id="Sec23"><title>Factors of COVID-19 Vaccine Acceptance in Japan</title><sec id="Sec24"><title>Theme 1. Environmental Backgrounds</title><sec id="FPar7"><title>Sub-Theme 1.1: Gradual Acceptance over Time</title><p id="Par36">Acceptance came over time (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>; Tokiya et al. <xref ref-type="bibr" rid="CR82">2022a</xref>; Hiraoka et al. <xref ref-type="bibr" rid="CR22">2022</xref>), as people gradually developed more trust and health literacy about safety and effectiveness as they see other&#x02019;s experiences (Harada and Watanabe <xref ref-type="bibr" rid="CR18">2021</xref>); for example, the experiences of healthcare professionals (Tokiya et al. <xref ref-type="bibr" rid="CR82">2022a</xref>), friends (Hiraoka et al. <xref ref-type="bibr" rid="CR22">2022</xref>), families (Higuchi et al. <xref ref-type="bibr" rid="CR19">2022</xref>) and the media reports (Hiraoka et al. <xref ref-type="bibr" rid="CR22">2022</xref>; Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>) that the majority of people didn&#x02019;t have severe side effects. Also, those who realized that the adverse reaction of the COVID-19 vaccine was not lethal recommended the COVID-19 vaccine to others. Especially, recommendations from crucial persons, such as family members (Higuchi et al. <xref ref-type="bibr" rid="CR19">2022</xref>), employers (Nomura et al. <xref ref-type="bibr" rid="CR55">2022</xref>), and doctors for pregnant women (Takahashi et al. <xref ref-type="bibr" rid="CR80">2022b</xref>), were reported. Thus, as time passed, the effectiveness and safety of the COVID-19 vaccine have been recognized, improving the vaccine acceptance rate among the general population (Nishida et al. <xref ref-type="bibr" rid="CR51">2021</xref>).</p></sec><sec id="FPar8"><title>Sub-Theme 1.2: Increased Access to Vaccination</title><p id="Par37">The establishment of large-scale vaccination sites by public agencies, universities, and large employers has improved accessibility for individuals to receive vaccines (Okubo et al. <xref ref-type="bibr" rid="CR62">2021b</xref>; Okamoto et al. <xref ref-type="bibr" rid="CR59">2022b</xref>; Mori et al. <xref ref-type="bibr" rid="CR45">2022</xref>; Tanaka et al. <xref ref-type="bibr" rid="CR81">2023</xref>). Additionally, opportunities for vaccination tied to employment, including job-related vaccination opportunities (Kadoya et al. <xref ref-type="bibr" rid="CR26">2021</xref>), have prompted the working population to receive vaccination.</p></sec><sec id="FPar9"><title>Sub-Theme 1.3: Fear of Infection Overwhelming Concerns of Safety and Efficacy</title><p id="Par38">People were more likely to get vaccinated when the threat of being infected tends to be lower than the concerns about vaccine safety and effectiveness (Niu et al. <xref ref-type="bibr" rid="CR52">2022a</xref>; Harada and Watanabe <xref ref-type="bibr" rid="CR18">2021</xref>). For example, the specter of infection due to a fourth wave of COVID-19 cases in the summer of 2021 in Japan has also driven many individuals to prioritize vaccination, motivated by the desire to avert a further rise in cases (Okubo et al. <xref ref-type="bibr" rid="CR62">2021b</xref>).</p></sec></sec><sec id="Sec25"><title>Theme 2. Factors Related to Japanese Cultural Values</title><sec id="FPar10"><title>Sub-Theme 2.1: Ethical Motivation Driven by the Responsibility to Protect Others</title><p id="Par39">A prevalent ethical drive to protect close people, such as family members, or vulnerable populations of society, including older adults and immunocompromised, has engendered a sense of responsibility to contribute to collective immunity (Machida et al. <xref ref-type="bibr" rid="CR40">2021a</xref>; Koji et al. <xref ref-type="bibr" rid="CR34">2022</xref>).</p></sec><sec id="FPar11"><title>Sub-Theme 2.2: Culture of Keeping Pace with Others</title><p id="Par40">Several studies indicated that Japanese people tend to be influenced by the behavior and attitudes of others, such as friends, colleagues, community members, etc., which could affect high vaccine acceptance of the first and second doses in Japan (Hiraoka et al. <xref ref-type="bibr" rid="CR22">2022</xref>; Kimura et al. <xref ref-type="bibr" rid="CR31">2022</xref>). This tendency is expressed as putting the interest of society over the individuals (Okubo et al. <xref ref-type="bibr" rid="CR62">2021b</xref>), caring social norms (Tokiya et al. <xref ref-type="bibr" rid="CR83">2022b</xref>; Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>), herding effect (Mori et al. <xref ref-type="bibr" rid="CR45">2022</xref>), and groupism (Kajiwara et al. <xref ref-type="bibr" rid="CR27">2022</xref>). It is also negatively stated, such as &#x0201c;peer pressure&#x0201d; (Mori et al. <xref ref-type="bibr" rid="CR45">2022</xref>) or &#x0201c;subjective pressure&#x0201d; (Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>). One qualitative study also identified a fear of burdening family or friends when suffering from a severe condition due to COVID-19 among older adults as an example of the tendency to care for others in Japanese culture (Kimura et al. <xref ref-type="bibr" rid="CR31">2022</xref>). On the other hand, this tendency could also influence vaccine hesitancy (Kajiwara et al. <xref ref-type="bibr" rid="CR27">2022</xref>).</p></sec><sec id="FPar12"><title>Sub-Theme 2.3: Fear of Stigma when being Infected</title><p id="Par41">Being afraid of stigma or discrimination when people were infected affected their willingness toward vaccination, both among older adults (Yoda and Katsuyama <xref ref-type="bibr" rid="CR92">2021</xref>; Koji et al. <xref ref-type="bibr" rid="CR34">2022</xref>) and the young generation (Miyachi et al. <xref ref-type="bibr" rid="CR44">2022</xref>).</p></sec></sec><sec id="Sec26"><title>Theme 3. Positive Attitudes toward Information Provided by Authorities</title><p id="Par42">Some studies indicated that trust in the information given by the government affected vaccine intention (Suzuki et al. <xref ref-type="bibr" rid="CR78">2022</xref>; Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>; Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>). Also, one study reported that trust in information from the local authorities, medical professionals, and the government was associated with vaccine acceptance (Nomura et al. <xref ref-type="bibr" rid="CR54">2021</xref>). Furthermore, those who rely on physicians, nurses, television, and medical information sites as their source of information on COVID-19 are less likely to be unsure or unwilling to receive vaccines.</p></sec></sec></sec><sec id="Sec27"><title>Discussion</title><p id="Par43">The ethical theory framework that we used in this paper highlights the tension and tradeoffs between individual autonomy and the common good. Our narrative review identified several key themes related to vaccine hesitancy, acceptance, and ethical controversy in the context of Japan, which is well-known as a country with one of the lowest vaccine confidence and trust in the world (de Figueiredo et al. <xref ref-type="bibr" rid="CR9">2020</xref>; Wong et al. <xref ref-type="bibr" rid="CR90">2021</xref>). Factors affecting vaccine hesitancy include concerns about vaccine safety, suspicion of vaccine inefficacy, mistrust of government, and low perceived threat. Also, for the factors influencing COVID-19 vaccine acceptance in Japan, environmental factors, factors related to Japanese cultural values, and individual ways of thinking were identified.</p><sec id="Sec28"><title>COVID-19 Vaccine Hesitancy in Japan</title><p id="Par44">This review revealed that concerns about vaccine safety and efficacy, mistrust of the government, and low susceptibility affected COVID-19 vaccine hesitancy in Japan. Two themes, concerns about vaccine safety, including three sub-themes: contextual skepticism, high expectations of medicine, misinformation, and mistrust of the government, have characteristics unique to Japan.</p><p id="Par45">First, contextual skepticism and mistrust of the government were related to the history of the anti-HPV and anti-MMR vaccine campaigns and the passive attitudes of the government toward such movements, affecting distrust of vaccine safety among the general population in Japan. These findings were consistent with previous studies about the history of vaccine hesitancy in Japan (Nakano <xref ref-type="bibr" rid="CR48">2023</xref>; Saitoh and Okabe <xref ref-type="bibr" rid="CR67">2012</xref>, <xref ref-type="bibr" rid="CR68">2014</xref>). The following Japan-specific nature might influence this factor that these historical events have persistently affected vaccine hesitancy in Japan.</p><p id="Par46">Second, high expectations for medicine also involve Japan-specific backgrounds as shown in several studies. In a cross-sectional study, it was reported that Japanese people do not tolerate being at risk of having adverse events by the vaccines (Hara et al. <xref ref-type="bibr" rid="CR17">2021</xref>). The medical system in Japan could cause it. Free access to medicine in Japan could make people believe that medicine should be perfect, making Japanese people less tolerant of side effects (Hara et al. <xref ref-type="bibr" rid="CR17">2021</xref>). Also, in a narrative review, it was said that &#x0201c;zero-risk,&#x0201d; which is a concept that &#x0201c;safety should be free from the risk,&#x0201d; is common in Japan (Nakamura <xref ref-type="bibr" rid="CR47">2021</xref>). Good access to medicine and Japanese society's &#x0201c;zero-risk&#x0201d; concept could affect COVID-19 vaccine hesitancy.</p><p id="Par47">Third, misinformation in Japan also has different aspects from other countries regarding information content. While conspiracy belief is one of the major reasons for vaccine hesitancy in Western countries, conspiracy theories were less prevalent in Japan (Tokiya et al. <xref ref-type="bibr" rid="CR83">2022b</xref>; Hornsey et al. <xref ref-type="bibr" rid="CR23">2018</xref>; Takahashi et al. <xref ref-type="bibr" rid="CR79">2022a</xref>). Shibuya mentioned that COVID-19 vaccine hesitancy in Japan was not connected to the political argument and defensive attitude caused by the objection or anxiety by being violated of individual rights or freedom, which might affect less conspiracy theories related to the COVID-19 vaccine (Wingfield-Hayes <xref ref-type="bibr" rid="CR89">2021</xref>).</p><p id="Par48">Based on the above, in light of the history of the anti-HPV and anti-MMR vaccine campaigns, it is imperative to call for appropriate information to the media and for promotion to fill in the gap between too-high expectations of zero risk and the potential for adverse events from vaccines.</p></sec><sec id="Sec29"><title>COVID-19 Vaccine Acceptance in Japan</title><p id="Par49">This study found that environmental factors, psychological factors, and positive attitudes toward information provided by authorities impacted COVID-19 vaccine acceptance in Japan. Although environmental factors and positive attitudes toward information provided by the authorities were shown in previous studies targeting other countries (Reiter et al. <xref ref-type="bibr" rid="CR65">2020</xref>; Soares et al. <xref ref-type="bibr" rid="CR74">2021</xref>; Hill et al. <xref ref-type="bibr" rid="CR21">2021</xref>), some psychological factors were unique to Japan. The Japanese culture of keeping pace with others, which is also called &#x0201c;groupism&#x0201d; (Kajiwara et al. <xref ref-type="bibr" rid="CR27">2022</xref>) and &#x0201c;caring social norms&#x0201d; (Tokiya et al. <xref ref-type="bibr" rid="CR83">2022b</xref>; Saitoh et al. <xref ref-type="bibr" rid="CR69">2022</xref>), contributed to increasing vaccine acceptance. This concept puts importance on how others think and follow others&#x02019; behavior rather than the opinion of the individuals. The culture of &#x0201c;groupism&#x0201d; and &#x0201c;social norm&#x0201d; have high affinity with three principles arguing that the public health benefits to achieve herd immunity should be prioritized over individual rights, noted in utilitarianism, contractualism, and the principle of duty of easy rescue. Also, in Japanese collectivistic Confucian culture, vaccination is viewed as a prosocial activity prioritizing societal benefit over personal liberties (Uehara et al. <xref ref-type="bibr" rid="CR85">2022</xref>). One previous study pointed out that such a tendency, which could be considered &#x0201c;altruism,&#x0201d; is more prominent among people with more opportunities for social participation because they have a higher risk of infecting others (Komada et al. <xref ref-type="bibr" rid="CR35">2023</xref>). However, this concept could involve the possibility of the individual's right to freedom being violated by the public interest as a whole (Komada et al. <xref ref-type="bibr" rid="CR35">2023</xref>). Other expressions of this tendency that are negatively paraphrased, such as &#x0201c;peer pressure&#x0201d; (Mori et al. <xref ref-type="bibr" rid="CR45">2022</xref>) or&#x0201d;subjective pressure&#x0201d; (Goodwin et al. <xref ref-type="bibr" rid="CR13">2022</xref>), might alert this ethical controversy. At present, there is, especially among youth, rejection of the duty to put their autonomy on hold in favor of making their own decisions (Yoshizaki <xref ref-type="bibr" rid="CR95">1997</xref>). Thus, it is essential to take into account both the traditional solid "groupism" nature among the Japanese and the recent tendency to focus on individualism to promote new vaccines, monitoring if the approach is pressuring people to limit their autonomy.</p></sec><sec id="Sec30"><title>Limitation</title><p id="Par50">The present study has some limitations. First, our research included only English and Japanese publications. However, we consider this approach suitable because the topic focuses on Japan, where both Japanese and English are used as primary languages for relevant literature. Also, our search was delimited to a specific database for literature search in Japanese. Notably, the Japanese articles database is widely acknowledged for its comprehensiveness, facilitating access to the most pertinent publications.</p><p id="Par51">Second, we did not assess the quality of the included studies. Rather than excluding studies based on bias assessment, we focused on exploring researchers' perspectives and inclusivity by incorporating available and eligible studies and identifying emerging themes. These themes appropriately capture the authors' experiences and viewpoints.</p></sec></sec><sec id="Sec31"><title>Conclusion</title><p id="Par52">The present study identified important reported factors associated with COVID-19 vaccine hesitancy and acceptance, determined researchers&#x02019; perspectives on the COVID-19 vaccine hesitancy in Japan, and discussed the ethical controversy of those reasons unique to Japan. Historical events, including the suspension of the HPV vaccine, the accessible medical system, and the culture of groupism and caring social norms, were considered factors unique to Japan. This synthesis of factors associated with COVID-19 vaccine hesitancy and acceptance and how those relate to ethical controversies can help public health policymakers, government agencies, and researchers design better prevention strategies and best practices among the general population regarding adherence to public safety regulations. Although reasons for vaccine hesitancy should be addressed and reasons for vaccine acceptance should be more focused on for more effective vaccine distribution, it is essential to understand the ethical controversy between benefits for society and freedom of individual rights. Healthcare professionals and public health experts should continue to dialogue and discuss with the critical mass and policymakers, considering their ethical standpoints.</p></sec></body><back><fn-group><fn><p>The original online version of this article was revised due to a retrospective Open Access order.</p></fn><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Change history</bold></p><p>12/6/2024</p><p>The original online version of this article was revised due to a retrospective Open Access order.</p></fn><fn><p><bold>Change history</bold></p><p>12/4/2024</p><p>A Correction to this paper has been published: 10.1007/s41649-024-00345-x</p></fn></fn-group><ack><title>Acknowledgements</title><p>The review team gratefully acknowledges the graduate course PHP 415/615: Public Health Ethics at Falk College Department of Public Health, Syracuse University, which inspired this narrative review. The student writing team is also grateful for their advice and consultation on research development.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>All authors contributed to the study's conception and design. Material preparation, data collection, and analysis were performed by MK and MKA. The first draft of the manuscript was written by MK, and all authors commented on previous versions of the manuscript. All authors read, edited, and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>The data of this study are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="data-availability"><title>Code Availability</title><p>Not applicable.</p></notes><notes><title>Declarations</title><notes id="FPar13" notes-type="COI-statement"><title>Conflict of Interests</title><p id="Par53">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Arashiro</surname><given-names>Takeshi</given-names></name><name><surname>Arima</surname><given-names>Yuzo</given-names></name><name><surname>Stucky</surname><given-names>Ashley</given-names></name><name><surname>Smith</surname><given-names>Chris</given-names></name><name><surname>Hibberd</surname><given-names>Martin</given-names></name><name><surname>Ariyoshi</surname><given-names>Koya</given-names></name><name><surname>Suzuki</surname><given-names>Motoi</given-names></name></person-group><article-title>Social and behavioral factors associated with lack of intent to receive COVID-19 vaccine, Japan</article-title><source>Emerging Infectious Diseases</source><year>2022</year><volume>28</volume><issue>9</issue><fpage>1909</fpage><lpage>1910</lpage><pub-id pub-id-type="doi">10.3201/eid2809.220300</pub-id><pub-id pub-id-type="pmid">35793812</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Arashiro, Takeshi, Yuzo Arima, Ashley Stucky, Chris Smith, Martin Hibberd, Koya Ariyoshi, and Motoi Suzuki. 2022. Social and behavioral factors associated with lack of intent to receive COVID-19 vaccine, Japan. <italic>Emerging Infectious Diseases</italic> 28 (9): 1909&#x02013;1910. 10.3201/eid2809.220300.<pub-id pub-id-type="pmid">35793812</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><mixed-citation publication-type="other">Ashford, Elizabeth, and Tim Mulgan. 2018. Contractualism. In <italic>The Stanford Encyclopedia of Philosophy</italic>, ed. Edward N. Zalta, Summer 2018. Metaphysics Research Lab, Stanford University. <ext-link ext-link-type="uri" xlink:href="https://plato.stanford.edu/archives/sum2018/entries/contractualism/">https://plato.stanford.edu/archives/sum2018/entries/contractualism/</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="other">Assistant Secretary for Public Affairs. 2022. HHS Provides $66.5 Million to Expand Community-Based Outreach Efforts to Increase COVID-19 Vaccinations. US Department of Health and Human Services, 8 February 2022. <ext-link ext-link-type="uri" xlink:href="https://www.hhs.gov/about/news/2022/02/08/hhs-provides-66-5-million-expand-community-based-outreach-efforts-increase-covid-19-vaccinations.html">https://www.hhs.gov/about/news/2022/02/08/hhs-provides-66-5-million-expand-community-based-outreach-efforts-increase-covid-19-vaccinations.html</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Baethge</surname><given-names>Christopher</given-names></name><name><surname>Goldbeck-Wood</surname><given-names>Sandra</given-names></name><name><surname>Mertens</surname><given-names>Stephan</given-names></name></person-group><article-title>SANRA-a scale for the quality assessment of narrative review articles</article-title><source>Research Integrity and Peer Review</source><year>2019</year><volume>4</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s41073-019-0064-8</pub-id><pub-id pub-id-type="pmid">30962953</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Baethge, Christopher, Sandra Goldbeck-Wood, and Stephan Mertens. 2019. SANRA-a scale for the quality assessment of narrative review articles. <italic>Research Integrity and Peer Review</italic> 4 (1): 5. 10.1186/s41073-019-0064-8.<pub-id pub-id-type="pmid">30962953</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>James</given-names></name><name><surname>Williams</surname><given-names>Bridget</given-names></name><name><surname>Ragonnet</surname><given-names>Romain</given-names></name><name><surname>Marais</surname><given-names>Ben</given-names></name><name><surname>Trauer</surname><given-names>James</given-names></name><name><surname>Savulescu</surname><given-names>Julian</given-names></name></person-group><article-title>Ethics of selective restriction of liberty in a pandemic</article-title><source>Journal of Medical Ethics</source><year>2021</year><volume>47</volume><issue>8</issue><fpage>553</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1136/medethics-2020-107104</pub-id><pub-id pub-id-type="pmid">34059520</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Cameron, James, Bridget Williams, Romain Ragonnet, Ben Marais, James Trauer, and Julian Savulescu. 2021. Ethics of selective restriction of liberty in a pandemic. <italic>Journal of Medical Ethics</italic> 47 (8): 553&#x02013;562. 10.1136/medethics-2020-107104.<pub-id pub-id-type="pmid">34059520</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Cheche</given-names></name><name><surname>Jiao</surname><given-names>Jiaxin</given-names></name><name><surname>Zhao</surname><given-names>Chunzhen</given-names></name><name><surname>Li</surname><given-names>Yingying</given-names></name></person-group><article-title>Does confucian culture affect public service motivation of grassroots public servants? Evidence from China</article-title><source>Frontiers in Psychology</source><year>2022</year><volume>13</volume><fpage>1066624</fpage><pub-id pub-id-type="doi">10.3389/fpsyg.2022.1066624</pub-id><pub-id pub-id-type="pmid">36743635</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Duan, Cheche, Jiaxin Jiao, Chunzhen Zhao, and Yingying Li. 2022. Does confucian culture affect public service motivation of grassroots public servants? Evidence from China. <italic>Frontiers in Psychology</italic> 13: 1066624. 10.3389/fpsyg.2022.1066624.<pub-id pub-id-type="pmid">36743635</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferawati</surname><given-names>Kiki</given-names></name><name><surname>Liew</surname><given-names>Kongmeng</given-names></name><name><surname>Aramaki</surname><given-names>Eiji</given-names></name><name><surname>Wakamiya</surname><given-names>Shoko</given-names></name></person-group><article-title>Monitoring mentions of COVID-19 vaccine side effects on japanese and indonesian twitter: Infodemiological study</article-title><source>JMIR Infodemiology</source><year>2022</year><volume>2</volume><issue>2</issue><fpage>e39504</fpage><pub-id pub-id-type="doi">10.2196/39504</pub-id><pub-id pub-id-type="pmid">36277140</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Ferawati, Kiki, Kongmeng Liew, Eiji Aramaki, and Shoko Wakamiya. 2022. Monitoring mentions of COVID-19 vaccine side effects on japanese and indonesian twitter: Infodemiological study. <italic>JMIR Infodemiology</italic> 2 (2): e39504. 10.2196/39504.<pub-id pub-id-type="pmid">36277140</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>Rossella</given-names></name></person-group><article-title>Writing narrative style literature reviews</article-title><source>Medical Writing</source><year>2015</year><volume>24</volume><issue>4</issue><fpage>230</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1179/2047480615Z.000000000329</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Ferrari, Rossella. 2015. Writing narrative style literature reviews. <italic>Medical Writing</italic> 24 (4): 230&#x02013;235. 10.1179/2047480615Z.000000000329.</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>de Figueiredo</surname><given-names>Alexandre</given-names></name><name><surname>Simas</surname><given-names>Clarissa</given-names></name><name><surname>Karafillakis</surname><given-names>Emilie</given-names></name><name><surname>Paterson</surname><given-names>Pauline</given-names></name><name><surname>Larson</surname><given-names>Heidi J</given-names></name></person-group><article-title>Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study</article-title><source>The Lancet</source><year>2020</year><volume>396</volume><issue>10255</issue><fpage>898</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31558-0</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">de Figueiredo, Alexandre, Clarissa Simas, Emilie Karafillakis, Pauline Paterson, and Heidi J. Larson. 2020. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study. <italic>The Lancet</italic> 396 (10255): 898&#x02013;908. 10.1016/S0140-6736(20)31558-0.</mixed-citation></citation-alternatives></ref><ref id="CR10"><mixed-citation publication-type="other">Ghaznavi, Cyrus, Daisuke Yoneoka, Takayuki Kawashima, Akifumi Eguchi, Michio Murakami, Stuart Gilmour, Satoshi Kaneko, et al. 2022. Factors associated with reversals of COVID-19 vaccination willingness: Results from two longitudinal, National Surveys in Japan 2021&#x02013;2022. <italic>Lancet Regional Health. Western Pacific</italic> 27:100540. 10.1016/j.lanwpc.2022.100540.</mixed-citation></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Giubilini</surname><given-names>Alberto</given-names></name></person-group><article-title>Vaccination ethics</article-title><source>British Medical Bulletin</source><year>2021</year><volume>137</volume><issue>1</issue><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1093/bmb/ldaa036</pub-id><pub-id pub-id-type="pmid">33367873</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Giubilini, Alberto. 2021. Vaccination ethics. <italic>British Medical Bulletin</italic> 137 (1): 4&#x02013;12. 10.1093/bmb/ldaa036.<pub-id pub-id-type="pmid">33367873</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Giubilini</surname><given-names>Alberto</given-names></name><name><surname>Douglas</surname><given-names>Thomas</given-names></name><name><surname>Savulescu</surname><given-names>Julian</given-names></name></person-group><article-title>The moral obligation to be vaccinated: utilitarianism, contractualism, and collective easy rescue</article-title><source>Medicine, Health Care, and Philosophy</source><year>2018</year><volume>21</volume><issue>4</issue><fpage>547</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1007/s11019-018-9829-y</pub-id><pub-id pub-id-type="pmid">29429063</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Giubilini, Alberto, Thomas Douglas, and Julian Savulescu. 2018. The moral obligation to be vaccinated: utilitarianism, contractualism, and collective easy rescue. <italic>Medicine, Health Care, and Philosophy</italic> 21 (4): 547&#x02013;560. 10.1007/s11019-018-9829-y.<pub-id pub-id-type="pmid">29429063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>Robin</given-names></name><name><surname>Ben-Ezra</surname><given-names>Menachem</given-names></name><name><surname>Takahashi</surname><given-names>Masahito</given-names></name><name><surname>Luu</surname><given-names>Lan-Anh Nguyen</given-names></name><name><surname>Borsfay</surname><given-names>Krisztina</given-names></name><name><surname>Kov&#x000e1;cs</surname><given-names>M&#x000f3;nika</given-names></name><name><surname>Hou</surname><given-names>Wai Kai</given-names></name><name><surname>Hamama-Raz</surname><given-names>Yaira</given-names></name><name><surname>Levin</surname><given-names>Yafit</given-names></name></person-group><article-title>Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary</article-title><source>Scientific Reports</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>439</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-03986-2</pub-id><pub-id pub-id-type="pmid">35013430</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Goodwin, Robin, Menachem Ben-Ezra, Masahito Takahashi, Lan-Anh Nguyen. Luu, Krisztina Borsfay, M&#x000f3;nika. Kov&#x000e1;cs, Wai Kai Hou, Yaira Hamama-Raz, and Yafit Levin. 2022. Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary. <italic>Scientific Reports</italic> 12 (1): 439. 10.1038/s41598-021-03986-2.<pub-id pub-id-type="pmid">35013430</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>Bart N</given-names></name><name><surname>Johnson</surname><given-names>Claire D</given-names></name><name><surname>Adams</surname><given-names>Alan</given-names></name></person-group><article-title>Writing narrative literature reviews for peer-reviewed journals: Secrets of the trade</article-title><source>Journal of Chiropractic Medicine</source><year>2006</year><volume>5</volume><issue>3</issue><fpage>101</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/S0899-3467(07)60142-6</pub-id><pub-id pub-id-type="pmid">19674681</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Green, Bart N., Claire D. Johnson, and Alan Adams. 2006. Writing narrative literature reviews for peer-reviewed journals: Secrets of the trade. <italic>Journal of Chiropractic Medicine</italic> 5 (3): 101&#x02013;117. 10.1016/S0899-3467(07)60142-6.<pub-id pub-id-type="pmid">19674681</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>Ann T</given-names></name><name><surname>Denniss</surname><given-names>A Robert</given-names></name></person-group><article-title>An introduction to writing narrative and systematic reviews - tasks, tips and traps for aspiring authors</article-title><source>Heart, Lung &#x00026; Circulation</source><year>2018</year><volume>27</volume><issue>7</issue><fpage>893</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1016/j.hlc.2018.03.027</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Gregory, Ann T., and A Robert Denniss. 2018. An introduction to writing narrative and systematic reviews - tasks, tips and traps for aspiring authors. <italic>Heart, Lung &#x00026; Circulation</italic> 27 (7): 893&#x02013;898. 10.1016/j.hlc.2018.03.027.</mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>Sharon J. B</given-names></name><name><surname>Yoshioka</surname><given-names>Eiji</given-names></name><name><surname>Ito</surname><given-names>Yoshiya</given-names></name><name><surname>Kishi</surname><given-names>Reiko</given-names></name></person-group><article-title>HPV vaccination crisis in Japan</article-title><source>The Lancet</source><year>2015</year><volume>385</volume><issue>9987</issue><fpage>2571</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)61152-7</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Hanley, Sharon J. B., Eiji Yoshioka, Yoshiya Ito, and Reiko Kishi. 2015. HPV vaccination crisis in Japan. <italic>The Lancet</italic> 385 (9987): 2571. 10.1016/S0140-6736(15)61152-7.</mixed-citation></citation-alternatives></ref><ref id="CR17"><mixed-citation publication-type="other">Hara, Megumi, Motoki Ishibashi, Atsushi Nakane, Takashi Nakano, and Yoshio Hirota. 2021. Differences in COVID-19 vaccine acceptance, hesitancy, and confidence between healthcare workers and the general population in Japan. <italic>Vaccines</italic> 9 (12): 1389. 10.3390/vaccines9121389.</mixed-citation></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>Takayuki</given-names></name><name><surname>Watanabe</surname><given-names>Takaaki</given-names></name></person-group><article-title>Changes in vaccine hesitancy in Japan across five months during the COVID-19 pandemic and its related factors</article-title><source>Vaccines</source><year>2021</year><volume>10</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.3390/vaccines10010025</pub-id><pub-id pub-id-type="pmid">35062686</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Harada, Takayuki, and Takaaki Watanabe. 2021. Changes in vaccine hesitancy in Japan across five months during the COVID-19 pandemic and its related factors. <italic>Vaccines</italic> 10 (1): 25. 10.3390/vaccines10010025.<pub-id pub-id-type="pmid">35062686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>C</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name><name><surname>Iwasaki</surname><given-names>Y</given-names></name><name><surname>Yorifuji</surname><given-names>T</given-names></name><name><surname>Yamazaki</surname><given-names>J</given-names></name><name><surname>Nasu</surname><given-names>Y</given-names></name><name><surname>Makino</surname><given-names>H</given-names></name></person-group><article-title>Questionnaire survey on COVID-19 vaccination at Okayama University in Japan: Factors promoting vaccination among young adults</article-title><source>Journal of Disaster Research</source><year>2022</year><volume>17</volume><issue>1</issue><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.20965/jdr.2022.p0021</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Higuchi, C., N. Matsumoto, Y. Iwasaki, T. Yorifuji, J. Yamazaki, Y. Nasu, and H. Makino. 2022. Questionnaire survey on COVID-19 vaccination at Okayama University in Japan: Factors promoting vaccination among young adults. <italic>Journal of Disaster Research</italic> 17 (1): 21&#x02013;30. 10.20965/jdr.2022.p0021.</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Hiiragi</surname><given-names>Kazuya</given-names></name><name><surname>Obata</surname><given-names>Soichiro</given-names></name><name><surname>Miyagi</surname><given-names>Etsuko</given-names></name><name><surname>Aoki</surname><given-names>Shigeru</given-names></name></person-group><article-title>The current status, attitudes, and practices concerning maternal pertussis vaccination in obstetric delivery facilities in Kanagawa Prefecture, Japan: A questionnaire survey</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2021</year><volume>17</volume><issue>11</issue><fpage>4235</fpage><lpage>4238</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1958609</pub-id><pub-id pub-id-type="pmid">35016490</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Hiiragi, Kazuya, Soichiro Obata, Etsuko Miyagi, and Shigeru Aoki. 2021. The current status, attitudes, and practices concerning maternal pertussis vaccination in obstetric delivery facilities in Kanagawa Prefecture, Japan: A questionnaire survey. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 17 (11): 4235&#x02013;4238. 10.1080/21645515.2021.1958609.<pub-id pub-id-type="pmid">35016490</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><mixed-citation publication-type="other">Hill, Jessica, Darlene Xiomara Rodriguez, and Paul N. McDaniel. 2021. Immigration status as a health care barrier in the USA during COVID-19. <italic>Journal of Migration and Health</italic> 4:100036. 10.1016/j.jmh.2021.100036.</mixed-citation></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Hiraoka</surname><given-names>Ko</given-names></name><name><surname>Nagata</surname><given-names>Tomohisa</given-names></name><name><surname>Mori</surname><given-names>Takahiro</given-names></name><name><surname>Ando</surname><given-names>Hajime</given-names></name><name><surname>Hino</surname><given-names>Ayako</given-names></name><name><surname>Tateishi</surname><given-names>Seiichiro</given-names></name><name><surname>Tsuji</surname><given-names>Mayumi</given-names></name><name><surname>Matsuda</surname><given-names>Shinya</given-names></name><name><surname>Fujino</surname><given-names>Yoshihisa</given-names></name></person-group><article-title>Association between willingness to receive the COVID-19 vaccine and sources of health information among Japanese workers: A cohort study</article-title><source>Environmental Health and Preventive Medicine</source><year>2022</year><volume>27</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1265/ehpm.21-00284</pub-id><pub-id pub-id-type="pmid">35289321</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Hiraoka, Ko., Tomohisa Nagata, Takahiro Mori, Hajime Ando, Ayako Hino, Seiichiro Tateishi, Mayumi Tsuji, Shinya Matsuda, and Yoshihisa Fujino. 2022. Association between willingness to receive the COVID-19 vaccine and sources of health information among Japanese workers: A cohort study. <italic>Environmental Health and Preventive Medicine</italic> 27: 2. 10.1265/ehpm.21-00284.<pub-id pub-id-type="pmid">35289321</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><mixed-citation publication-type="other">Hornsey, M., Emily A. Harris, and Kelly S. Fielding. 2018. The psychological roots of anti-vaccination attitudes. <italic>Health Psychology</italic> 37(4): 307&#x02013;15. <ext-link ext-link-type="uri" xlink:href="https://www.apa.org/pubs/journals/releases/hea-hea0000586.pdf">https://www.apa.org/pubs/journals/releases/hea-hea0000586.pdf</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Hosokawa</surname><given-names>Yoshihiko</given-names></name><name><surname>Okawa</surname><given-names>Sumiyo</given-names></name><name><surname>Hori</surname><given-names>Ai</given-names></name><name><surname>Morisaki</surname><given-names>Naho</given-names></name><name><surname>Takahashi</surname><given-names>Yoko</given-names></name><name><surname>Fujiwara</surname><given-names>Takeo</given-names></name><name><surname>Nakayama</surname><given-names>Shoji F</given-names></name><name><surname>Hamada</surname><given-names>Hiromi</given-names></name><name><surname>Satoh</surname><given-names>Toyomi</given-names></name><name><surname>Tabuchi</surname><given-names>Takahiro</given-names></name></person-group><article-title>The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: An internet-based cross-sectional study in Japan</article-title><source>Journal of Epidemiology / Japan Epidemiological Association</source><year>2022</year><volume>32</volume><issue>4</issue><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.2188/jea.JE20210458</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hosokawa, Yoshihiko, Sumiyo Okawa, Ai. Hori, Naho Morisaki, Yoko Takahashi, Takeo Fujiwara, Shoji F. Nakayama, Hiromi Hamada, Toyomi Satoh, and Takahiro Tabuchi. 2022. The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: An internet-based cross-sectional study in Japan. <italic>Journal of Epidemiology / Japan Epidemiological Association</italic> 32 (4): 188&#x02013;194. 10.2188/jea.JE20210458.</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimaru</surname><given-names>Tomohiro</given-names></name><name><surname>Okawara</surname><given-names>Makoto</given-names></name><name><surname>Ando</surname><given-names>Hajime</given-names></name><name><surname>Hino</surname><given-names>Ayako</given-names></name><name><surname>Nagata</surname><given-names>Tomohisa</given-names></name><name><surname>Tateishi</surname><given-names>Seiichiro</given-names></name><name><surname>Tsuji</surname><given-names>Mayumi</given-names></name><name><surname>Matsuda</surname><given-names>Shinya</given-names></name><name><surname>Fujino</surname><given-names>Yoshihisa</given-names></name><collab>CORoNaWork Project</collab></person-group><article-title>Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2021</year><volume>17</volume><issue>11</issue><fpage>3975</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1947098</pub-id><pub-id pub-id-type="pmid">34213406</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Ishimaru, Tomohiro, Makoto Okawara, Hajime Ando, Ayako Hino, Tomohisa Nagata, Seiichiro Tateishi, Mayumi Tsuji, Shinya Matsuda, Yoshihisa Fujino, CORoNaWork Project. 2021. Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 17 (11): 3975&#x02013;81. 10.1080/21645515.2021.1947098.<pub-id pub-id-type="pmid">34213406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><mixed-citation publication-type="other">Kadoya, Yoshihiko, Somtip Watanapongvanich, Pattaphol Yuktadatta, Pongpat Putthinun, Stella T. Lartey, and Mostafa Saidur Rahim Khan. 2021. Willing or hesitant? A socioeconomic study on the potential acceptance of COVID-19 vaccine in Japan. <italic>International Journal of Environmental Research and Public Health</italic> 18 (9): 4864. 10.3390/ijerph18094864.</mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="other">Kajiwara, Shihoko, Naomi Akiyama, and Michio Ohta. 2022. Intentions regarding COVID-19 vaccination in females aged 15&#x02013;49 years. <italic>Vaccines</italic> 10 (2): 336. 10.3390/vaccines10020336.</mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="other">Kawata, Keisuke, and Masaki Nakabayashi. 2021. Determinants of COVID-19 vaccine preference: A survey study in Japan. <italic>SSM - Population Health</italic> 15:100902. 10.1016/j.ssmph.2021.100902.</mixed-citation></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>Mostafa Saidur Rahim</given-names></name><name><surname>Watanapongvanich</surname><given-names>Somtip</given-names></name><name><surname>Kadoya</surname><given-names>Yoshihiko</given-names></name></person-group><article-title>COVID-19 vaccine hesitancy among the younger generation in Japan</article-title><source>International Journal of Environmental Research and Public Health</source><year>2021</year><volume>18</volume><issue>21</issue><fpage>11702</fpage><pub-id pub-id-type="doi">10.3390/ijerph182111702</pub-id><pub-id pub-id-type="pmid">34770216</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Khan, Mostafa Saidur Rahim , Somtip Watanapongvanich, and Yoshihiko Kadoya. 2021. COVID-19 vaccine hesitancy among the younger generation in Japan. <italic>International Journal of Environmental Research and Public Health</italic> 18 (21): 11702. 10.3390/ijerph182111702.<pub-id pub-id-type="pmid">34770216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><mixed-citation publication-type="other">Khan, Mostafa Saidur Rahim, Trinh Xuan Thi Nguyen, Sumeet Lal, Somtip Watanapongvanich, and Yoshihiko Kadoya. 2022. Hesitancy towards the third dose of COVID-19 vaccine among the younger generation in Japan. <italic>International Journal of Environmental Research and Public Health</italic> 19 (12). 10.3390/ijerph19127041.</mixed-citation></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>Shuhei</given-names></name><name><surname>Horiguchi</surname><given-names>Sachiko</given-names></name><name><surname>Goto</surname><given-names>Ryohei</given-names></name><name><surname>Iida</surname><given-names>Junko</given-names></name><name><surname>Ozone</surname><given-names>Sachiko</given-names></name><name><surname>Kaneko</surname><given-names>Makoto</given-names></name><name><surname>Teruyama</surname><given-names>Junko</given-names></name><name><surname>Hama</surname><given-names>Yusuke</given-names></name><name><surname>Haruta</surname><given-names>Junji</given-names></name><name><surname>Miyachi</surname><given-names>Junichiro</given-names></name></person-group><article-title>How have Japanese primary care physicians carried out vaccinations against COVID-19?: Attempts at making the non-scalable &#x02018;scalable&#x02019;</article-title><source>F1000Research</source><year>2022</year><volume>11</volume><issue>1268</issue><fpage>1268</fpage><pub-id pub-id-type="doi">10.12688/f1000research.126366.1</pub-id><pub-id pub-id-type="pmid">37638132</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Kimura, Shuhei, Sachiko Horiguchi, Ryohei Goto, Junko Iida, Sachiko Ozone, Makoto Kaneko, Junko Teruyama, Yusuke Hama, Junji Haruta, and Junichiro Miyachi. 2022. How have Japanese primary care physicians carried out vaccinations against COVID-19?: Attempts at making the non-scalable &#x02018;scalable.&#x02019; <italic>F1000Research</italic> 11 (1268): 1268. 10.12688/f1000research.126366.1.<pub-id pub-id-type="pmid">37638132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Kitano</surname><given-names>Taito</given-names></name></person-group><article-title>Close the gap for routine mumps vaccination in Japan</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2021</year><volume>17</volume><issue>1</issue><fpage>205</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1080/21645515.2020.1765619</pub-id><pub-id pub-id-type="pmid">32530735</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kitano, Taito. 2021. Close the gap for routine mumps vaccination in Japan. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 17 (1): 205&#x02013;210. 10.1080/21645515.2020.1765619.<pub-id pub-id-type="pmid">32530735</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>Takaaki</given-names></name><name><surname>Nishina</surname><given-names>Yuka</given-names></name><name><surname>Tomoi</surname><given-names>Hana</given-names></name><name><surname>Harada</surname><given-names>Ko</given-names></name><name><surname>Tanaka</surname><given-names>Kyuto</given-names></name><name><surname>Matsumoto</surname><given-names>Eiyu</given-names></name><name><surname>Horimukai</surname><given-names>Kenta</given-names></name><etal/></person-group><article-title>Corowa-Kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><issue>32</issue><fpage>4654</fpage><lpage>4662</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.06.007</pub-id><pub-id pub-id-type="pmid">35750541</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Kobayashi, Takaaki, Yuka Nishina, Hana Tomoi, Ko. Harada, Kyuto Tanaka, Eiyu Matsumoto, Kenta Horimukai, et al. 2022. Corowa-Kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021. <italic>Vaccine</italic> 40 (32): 4654&#x02013;4662. 10.1016/j.vaccine.2022.06.007.<pub-id pub-id-type="pmid">35750541</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Koji</surname><given-names>Mori</given-names></name><name><surname>Tomohiro</surname><given-names>Ishimaru</given-names></name><name><surname>Yuichi</surname><given-names>Kobayashi</given-names></name><name><surname>Takahiro</surname><given-names>Mori</given-names></name><name><surname>Tomohisa</surname><given-names>Nagata</given-names></name></person-group><article-title>Vaccine hesitancy: Factors influencing intention to vaccinate and the workplace</article-title><source>Occupational Health Review</source><year>2022</year><volume>34</volume><issue>3</issue><fpage>179</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.34354/ohpfrev.34.3_179</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Koji, Mori, Ishimaru Tomohiro, Kobayashi Yuichi, Mori Takahiro, and Nagata Tomohisa. 2022. Vaccine hesitancy: Factors influencing intention to vaccinate and the workplace. <italic>Occupational Health Review</italic> 34 (3): 179&#x02013;98. 10.34354/ohpfrev.34.3_179.</mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Komada</surname><given-names>Mayuko T</given-names></name><name><surname>Lee</surname><given-names>Jung Su</given-names></name><name><surname>Watanabe</surname><given-names>Etsuko</given-names></name><name><surname>Nakazawa</surname><given-names>Eisuke</given-names></name><name><surname>Mori</surname><given-names>Katsumi</given-names></name><name><surname>Akabayashi</surname><given-names>Akira</given-names></name></person-group><article-title>Factors of influenza vaccine inoculation and non-inoculation behavior of community-dwelling residents in Japan: Suggestions for vaccine policy and public health ethics after COVID-19</article-title><source>Vaccine: X</source><year>2023</year><volume>13</volume><fpage>100245</fpage><pub-id pub-id-type="doi">10.1016/j.jvacx.2022.100245</pub-id><pub-id pub-id-type="pmid">36530570</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Komada, Mayuko T., Jung Su Lee, Etsuko Watanabe, Eisuke Nakazawa, Katsumi Mori, and Akira Akabayashi. 2023. Factors of influenza vaccine inoculation and non-inoculation behavior of community-dwelling residents in Japan: Suggestions for vaccine policy and public health ethics after COVID-19. <italic>Vaccine: X</italic> 13: 100245. 10.1016/j.jvacx.2022.100245.<pub-id pub-id-type="pmid">36530570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuipers</surname><given-names>Thomas</given-names></name><name><surname>van de Pas</surname><given-names>Remco</given-names></name><name><surname>Krumeich</surname><given-names>Anja</given-names></name></person-group><article-title>Is the healthcare provision in the Netherlands compliant with universal health coverage based on the right to health? A narrative literature review</article-title><source>Globalization and Health</source><year>2022</year><volume>18</volume><issue>1</issue><fpage>38</fpage><pub-id pub-id-type="doi">10.1186/s12992-022-00831-7</pub-id><pub-id pub-id-type="pmid">35366916</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Kuipers, Thomas, Remco van de Pas, and Anja Krumeich. 2022. Is the healthcare provision in the Netherlands compliant with universal health coverage based on the right to health? A narrative literature review. <italic>Globalization and Health</italic> 18 (1): 38. 10.1186/s12992-022-00831-7.<pub-id pub-id-type="pmid">35366916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>Jeffrey V</given-names></name><name><surname>Ratzan</surname><given-names>Scott C</given-names></name><name><surname>Palayew</surname><given-names>Adam</given-names></name><name><surname>Gostin</surname><given-names>Lawrence O</given-names></name><name><surname>Larson</surname><given-names>Heidi J</given-names></name><name><surname>Rabin</surname><given-names>Kenneth</given-names></name><name><surname>Kimball</surname><given-names>Spencer</given-names></name><name><surname>El-Mohandes</surname><given-names>Ayman</given-names></name></person-group><article-title>A global survey of potential acceptance of a COVID-19 vaccine</article-title><source>Nature Medicine</source><year>2021</year><volume>27</volume><issue>2</issue><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-1124-9</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Lazarus, Jeffrey V., Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball, and Ayman El-Mohandes. 2021. A global survey of potential acceptance of a COVID-19 vaccine. <italic>Nature Medicine</italic> 27 (2): 225&#x02013;228. 10.1038/s41591-020-1124-9.</mixed-citation></citation-alternatives></ref><ref id="CR38"><mixed-citation publication-type="other">Lin, Cheryl, Pikuei Tu, and Leslie M. Beitsch. 2020. Confidence and receptivity for COVID-19 vaccines: A rapid systematic review. <italic>Vaccines</italic> 9 (1): 16. 10.3390/vaccines9010016.</mixed-citation></ref><ref id="CR39"><mixed-citation publication-type="other">Liu, Zixuan. 2018. The influence of confucianism on East Asian countries. In <italic>Proceedings of the 4th International Conference on Arts, Design and Contemporary Education (ICADCE 2018)</italic>, 77&#x02013;79. 10.2991/ICADCE-18.2018.14.</mixed-citation></ref><ref id="CR40"><mixed-citation publication-type="other">Machida, Masaki, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, Tomoko Takamiya, et al. 2021a. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. <italic>Vaccines</italic> 9 (3): 210. 10.3390/vaccines9030210.</mixed-citation></ref><ref id="CR41"><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Machida</surname><given-names>Masaki</given-names></name><name><surname>Nakamura</surname><given-names>Itaru</given-names></name><name><surname>Kojima</surname><given-names>Takako</given-names></name><name><surname>Saito</surname><given-names>Reiko</given-names></name><name><surname>Nakaya</surname><given-names>Tomoki</given-names></name><name><surname>Hanibuchi</surname><given-names>Tomoya</given-names></name><name><surname>Takamiya</surname><given-names>Tomoko</given-names></name><etal/></person-group><article-title>Trends in COVID-19 vaccination intent from pre- to post-COVID-19 vaccine distribution and their associations with the 5C psychological antecedents of vaccination by sex and age in Japan</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2021</year><volume>17</volume><issue>11</issue><fpage>3954</fpage><lpage>3962</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1968217</pub-id><pub-id pub-id-type="pmid">34723753</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Machida, Masaki, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, Tomoko Takamiya, et al. 2021b. Trends in COVID-19 vaccination intent from pre- to post-COVID-19 vaccine distribution and their associations with the 5C psychological antecedents of vaccination by sex and age in Japan. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 17 (11): 3954&#x02013;3962. 10.1080/21645515.2021.1968217.<pub-id pub-id-type="pmid">34723753</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><mixed-citation publication-type="other">Mathieu, Edouard, Hannah Ritchie, Lucas Rod&#x000e9;s-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, et al. 2020. Coronavirus pandemic (COVID-19). <italic>Our World in Data</italic>, March. <ext-link ext-link-type="uri" xlink:href="https://ourworldindata.org/covid-vaccinations">https://ourworldindata.org/covid-vaccinations</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR43"><mixed-citation publication-type="other">Ministry of Health, Labour, and Welfare, Japan. 2020. About development of the COVID-19 vaccine. Ministry of Health, Labour, and Welfare, Japan, 8 September 2020. <ext-link ext-link-type="uri" xlink:href="https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00223.html">https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00223.html</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR44"><mixed-citation publication-type="other">Miyachi, Takashi, Yuta Sugano, Shizune Tanaka, Junko Hirayama, Fumio Yamamoto, and Kyoko Nomura. 2022. COVID-19 vaccine intention and knowledge, literacy, and health beliefs among Japanese University Students. <italic>Vaccines</italic> 10 (6): 893. 10.3390/vaccines10060893.</mixed-citation></ref><ref id="CR45"><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>Koji</given-names></name><name><surname>Mori</surname><given-names>Takahiro</given-names></name><name><surname>Nagata</surname><given-names>Tomohisa</given-names></name><name><surname>Ando</surname><given-names>Hajime</given-names></name><name><surname>Hino</surname><given-names>Ayako</given-names></name><name><surname>Tateishi</surname><given-names>Seiichiro</given-names></name><name><surname>Tsuji</surname><given-names>Mayumi</given-names></name><name><surname>Muramatsu</surname><given-names>Keiji</given-names></name><name><surname>Fujino</surname><given-names>Yoshihisa</given-names></name></person-group><article-title>COVID-19 vaccination coverage by company size and the effects of workplace vaccination program in Japan: A cohort study</article-title><source>Environmental Health and Preventive Medicine</source><year>2022</year><volume>27</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1265/ehpm.22-00091</pub-id><pub-id pub-id-type="pmid">35786684</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Mori, Koji, Takahiro Mori, Tomohisa Nagata, Hajime Ando, Ayako Hino, Seiichiro Tateishi, Mayumi Tsuji, Keiji Muramatsu, and Yoshihisa Fujino. 2022. COVID-19 vaccination coverage by company size and the effects of workplace vaccination program in Japan: A cohort study. <italic>Environmental Health and Preventive Medicine</italic> 27: 29. 10.1265/ehpm.22-00091.<pub-id pub-id-type="pmid">35786684</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakada</surname><given-names>Haruka</given-names></name><name><surname>Takashima</surname><given-names>Kyoko</given-names></name><name><surname>Maru</surname><given-names>Yuichi</given-names></name><name><surname>Ikka</surname><given-names>Tsunakuni</given-names></name><name><surname>Yuji</surname><given-names>Koichiro</given-names></name><name><surname>Yoshida</surname><given-names>Sachie</given-names></name><name><surname>Matsui</surname><given-names>Kenji</given-names></name></person-group><article-title>Public attitudes toward COVID-19 vaccinations before dawn in Japan: Ethics and future perspectives</article-title><source>Asian Bioethics Review</source><year>2022</year><volume>14</volume><issue>3</issue><fpage>287</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1007/s41649-022-00207-4</pub-id><pub-id pub-id-type="pmid">35573157</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Nakada, Haruka, Kyoko Takashima, Yuichi Maru, Tsunakuni Ikka, Koichiro Yuji, Sachie Yoshida, and Kenji Matsui. 2022. Public attitudes toward COVID-19 vaccinations before dawn in Japan: Ethics and future perspectives. <italic>Asian Bioethics Review</italic> 14 (3): 287&#x02013;302. 10.1007/s41649-022-00207-4.<pub-id pub-id-type="pmid">35573157</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Masayoshi</given-names></name></person-group><article-title>Consideration about the society after the COVID-19</article-title><source>Industrial Health</source><year>2021</year><volume>59</volume><issue>5</issue><fpage>293</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.2486/indhealth.2021-0082</pub-id><pub-id pub-id-type="pmid">34421101</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Nakamura, Masayoshi. 2021. Consideration about the society after the COVID-19. <italic>Industrial Health</italic> 59 (5): 293&#x02013;297. 10.2486/indhealth.2021-0082.<pub-id pub-id-type="pmid">34421101</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>Takashi</given-names></name></person-group><article-title>Changes in vaccination administration in Japan</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><issue>16</issue><fpage>2723</fpage><lpage>2728</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.03.020</pub-id><pub-id pub-id-type="pmid">36933981</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Nakano, Takashi. 2023. Changes in vaccination administration in Japan. <italic>Vaccine</italic> 41 (16): 2723&#x02013;2728. 10.1016/j.vaccine.2023.03.020.<pub-id pub-id-type="pmid">36933981</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>Tetsuo</given-names></name></person-group><article-title>Vaccine chronicle in Japan</article-title><source>Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy</source><year>2013</year><volume>19</volume><issue>5</issue><fpage>787</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1007/s10156-013-0641-6</pub-id><pub-id pub-id-type="pmid">23835871</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Nakayama, Tetsuo. 2013. Vaccine chronicle in Japan. <italic>Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy</italic> 19 (5): 787&#x02013;798. 10.1007/s10156-013-0641-6.<pub-id pub-id-type="pmid">23835871</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><mixed-citation publication-type="other">National Institute of Infectious Diseases, Center for Epidemiology of Infectious Diseases and Bacteria Division II. 2022. Epidemiology of pertussis-reported cases in Japan based on overall reported surveillance (updated information). Epidemiology Week 1&#x02013;53. 25 December 2022. <ext-link ext-link-type="uri" xlink:href="https://www.niid.go.jp/niid/ja/pertussis-m/pertussis-idwrs/11721-2020-1-53.html">https://www.niid.go.jp/niid/ja/pertussis-m/pertussis-idwrs/11721-2020-1-53.html</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="other">Nishida, Yu, Shuhei Hosomi, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, et al. 2021. Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan. <italic>Healthcare</italic> 10 (1): 6. 10.3390/healthcare10010006.</mixed-citation></ref><ref id="CR52"><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>Qian</given-names></name><name><surname>Liu</surname><given-names>Junyu</given-names></name><name><surname>Kato</surname><given-names>Masaya</given-names></name><name><surname>Nagai-Tanima</surname><given-names>Momoko</given-names></name><name><surname>Aoyama</surname><given-names>Tomoki</given-names></name></person-group><article-title>The effect of fear of infection and sufficient vaccine reservation information on rapid COVID-19 vaccination in Japan: Evidence from a retrospective twitter analysis</article-title><source>Journal of Medical Internet Research</source><year>2022</year><volume>24</volume><issue>6</issue><fpage>e37466</fpage><pub-id pub-id-type="doi">10.2196/37466</pub-id><pub-id pub-id-type="pmid">35649182</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Niu, Qian, Junyu Liu, Masaya Kato, Momoko Nagai-Tanima, and Tomoki Aoyama. 2022a. The effect of fear of infection and sufficient vaccine reservation information on rapid COVID-19 vaccination in Japan: Evidence from a retrospective twitter analysis. <italic>Journal of Medical Internet Research</italic> 24 (6): e37466. 10.2196/37466.<pub-id pub-id-type="pmid">35649182</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>Qian</given-names></name><name><surname>Liu</surname><given-names>Junyu</given-names></name><name><surname>Kato</surname><given-names>Masaya</given-names></name><name><surname>Shinohara</surname><given-names>Yuki</given-names></name><name><surname>Matsumura</surname><given-names>Natsuki</given-names></name><name><surname>Aoyama</surname><given-names>Tomoki</given-names></name><name><surname>Nagai-Tanima</surname><given-names>Momoko</given-names></name></person-group><article-title>Public opinion and sentiment before and at the beginning of COVID-19 vaccinations in Japan: Twitter analysis</article-title><source>JMIR Infodemiology</source><year>2022</year><volume>2</volume><issue>1</issue><fpage>e32335</fpage><pub-id pub-id-type="doi">10.2196/32335</pub-id><pub-id pub-id-type="pmid">35578643</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Niu, Qian, Junyu Liu, Masaya Kato, Yuki Shinohara, Natsuki Matsumura, Tomoki Aoyama, and Momoko Nagai-Tanima. 2022b. Public opinion and sentiment before and at the beginning of COVID-19 vaccinations in Japan: Twitter analysis. <italic>JMIR Infodemiology</italic> 2 (1): e32335. 10.2196/32335.<pub-id pub-id-type="pmid">35578643</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><mixed-citation publication-type="other">Nomura, Shuhei, Akifumi Eguchi, Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Michio Murakami, Haruka Sakamoto, et al. 2021. Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A Large cross-sectional national survey. <italic>Lancet Regional Health. Western Pacific</italic> 14:100223. 10.1016/j.lanwpc.2021.100223.</mixed-citation></ref><ref id="CR55"><mixed-citation publication-type="other">Nomura, Shuhei, Akifumi Eguchi, Daisuke Yoneoka, Michio Murakami, Cyrus Ghaznavi, Stuart Gilmour, Satoshi Kaneko, et al. 2022. Characterising reasons for reversals of COVID-19 vaccination hesitancy among Japanese people: One-year follow-up survey. <italic>Lancet Regional Health. Western Pacific</italic> 27:100541. 10.1016/j.lanwpc.2022.100541.</mixed-citation></ref><ref id="CR56"><mixed-citation publication-type="other">Ochola, Elizabeth A. 2023. Vaccine hesitancy in Sub-Saharan Africa in the context of COVID-19 vaccination exercise: A systematic review. <italic>Diseases </italic>11 (1): 32. 10.3390/diseases11010032.</mixed-citation></ref><ref id="CR57"><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Odani</surname><given-names>Satomi</given-names></name><name><surname>Koyama</surname><given-names>Shihoko</given-names></name><name><surname>Katsumi</surname><given-names>Yuichi</given-names></name><name><surname>Miyashiro</surname><given-names>Isao</given-names></name></person-group><article-title>Attitudes toward COVID-19 vaccination during the state of emergency in Osaka, Japan</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><issue>12</issue><fpage>e0279481</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0279481</pub-id><pub-id pub-id-type="pmid">36584068</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Odani, Satomi, Shihoko Koyama, Yuichi Katsumi, and Isao Miyashiro. 2022. Attitudes toward COVID-19 vaccination during the state of emergency in Osaka, Japan. <italic>PLoS ONE</italic> 17 (12): e0279481. 10.1371/journal.pone.0279481.<pub-id pub-id-type="pmid">36584068</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>Shohei</given-names></name><name><surname>Kamimura</surname><given-names>Kazuki</given-names></name><name><surname>Komamura</surname><given-names>Kohei</given-names></name></person-group><article-title>COVID-19 vaccine hesitancy and vaccine passports: A cross-sectional conjoint experiment in Japan</article-title><source>British Medical Journal Open</source><year>2022</year><volume>12</volume><issue>6</issue><fpage>e060829</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2022-060829</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Okamoto, Shohei, Kazuki Kamimura, and Kohei Komamura. 2022a. COVID-19 vaccine hesitancy and vaccine passports: A cross-sectional conjoint experiment in Japan. <italic>British Medical Journal Open</italic> 12 (6): e060829. 10.1136/bmjopen-2022-060829.</mixed-citation></citation-alternatives></ref><ref id="CR59"><mixed-citation publication-type="other">Okamoto, Yuri, Toru Hiyama, Yoshie Miyake, Atsuo Yoshino, Shunsuke Miyauchi, and Junko Tanaka. 2022b. Attitudes and Behavior toward COVID-19 Vaccination in Japanese University Students: A Cross-Sectional Study. <italic>Vaccines</italic> 10 (6): 863. 10.3390/vaccines10060863.</mixed-citation></ref><ref id="CR60"><mixed-citation publication-type="other">Okubo, Ryo, and Takashi Yoshioka. 2021. Psychological distress and vaccine hesitancy during the coronavirus disease 2019 pandemic in Japan. &#x04e88;&#x09632;&#x07cbe;&#x0795e;&#x0533b;&#x05b66; 6(1): 3&#x02013;15. 10.24591/jseip.6.1_3.</mixed-citation></ref><ref id="CR61"><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>Ryo</given-names></name><name><surname>Yoshioka</surname><given-names>Takashi</given-names></name><name><surname>Ohfuji</surname><given-names>Satoko</given-names></name><name><surname>Matsuo</surname><given-names>Takahiro</given-names></name><name><surname>Tabuchi</surname><given-names>Takahiro</given-names></name></person-group><article-title>COVID-19 vaccine hesitancy and its associated factors in Japan</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><issue>6</issue><fpage>662</fpage><pub-id pub-id-type="doi">10.3390/vaccines9060662</pub-id><pub-id pub-id-type="pmid">34204465</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Okubo, Ryo, Takashi Yoshioka, Satoko Ohfuji, Takahiro Matsuo, and Takahiro Tabuchi. 2021a. COVID-19 vaccine hesitancy and its associated factors in Japan. <italic>Vaccines</italic> 9 (6): 662. 10.3390/vaccines9060662.<pub-id pub-id-type="pmid">34204465</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><mixed-citation publication-type="other">Okubo, Toshihiro, Atsushi Inoue, and Kozue Sekijima. 2021. Who got vaccinated for COVID-19? Evidence from Japan. <italic>Vaccines</italic> 9 (12): 1505. 10.3390/vaccines9121505.</mixed-citation></ref><ref id="CR63"><mixed-citation publication-type="other">Pavey, Louisa, Amanda Rotella, and Gaelle Vall&#x000e9;e-Tourangeau. 2024. Moral obligation, autonomous motivation and vaccine hesitancy: Highlighting moral obligation increases reactance in hesitant individuals. <italic>Applied Psychology. Health and Well-Being</italic>, 1 April 2024. 10.1111/aphw.12540.</mixed-citation></ref><ref id="CR64"><mixed-citation publication-type="other">Qunaibi, Eyad A., Mohamed Helmy, Iman Basheti, and Iyad Sultan. 2021. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs. <italic>eLife</italic> 10:e68038. 10.7554/eLife.68038.</mixed-citation></ref><ref id="CR65"><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>Paul L</given-names></name><name><surname>Pennell</surname><given-names>Michael L</given-names></name><name><surname>Katz</surname><given-names>Mira L</given-names></name></person-group><article-title>Acceptability of a COVID-19 vaccine among adults in the United States: How Many people would get vaccinated?</article-title><source>Vaccine</source><year>2020</year><volume>38</volume><issue>42</issue><fpage>6500</fpage><lpage>6507</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2020.08.043</pub-id><pub-id pub-id-type="pmid">32863069</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Reiter, Paul L., Michael L. Pennell, and Mira L. Katz. 2020. Acceptability of a COVID-19 vaccine among adults in the United States: How Many people would get vaccinated? <italic>Vaccine</italic> 38 (42): 6500&#x02013;6507. 10.1016/j.vaccine.2020.08.043.<pub-id pub-id-type="pmid">32863069</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><mixed-citation publication-type="other">Saitoh, Akihiko. 2014. &#x0904e;&#x053bb;&#x030fb;&#x073fe;&#x05728;&#x030fb;&#x0672a;&#x06765;&#x03067;&#x08aad;&#x0307f;&#x089e3;&#x0304f;, &#x065e5;&#x0672c;&#x0306e;&#x04e88;&#x09632;&#x063a5;&#x07a2e;&#x05236;&#x05ea6; (&#x09f4b;&#x085e4;&#x0662d;&#x05f66;) . Igaku-Shoin, 6 January 2014. <ext-link ext-link-type="uri" xlink:href="https://www.igaku-shoin.co.jp/paper/archive/y2014/PA03058_02">https://www.igaku-shoin.co.jp/paper/archive/y2014/PA03058_02</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR67"><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>Akihiko</given-names></name><name><surname>Okabe</surname><given-names>Nobuhiko</given-names></name></person-group><article-title>Current issues with the immunization program in Japan: Can we fill the &#x02018;vaccine gap&#x02019;?</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>32</issue><fpage>4752</fpage><lpage>4756</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.04.026</pub-id><pub-id pub-id-type="pmid">22521841</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Saitoh, Akihiko, and Nobuhiko Okabe. 2012. Current issues with the immunization program in Japan: Can we fill the &#x02018;vaccine gap&#x02019;? <italic>Vaccine</italic> 30 (32): 4752&#x02013;4756. 10.1016/j.vaccine.2012.04.026.<pub-id pub-id-type="pmid">22521841</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>Akihiko</given-names></name><name><surname>Okabe</surname><given-names>Nobuhiko</given-names></name></person-group><article-title>Recent progress and concerns regarding the Japanese immunization program: Addressing the &#x02018;vaccine gap&#x02019;</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><issue>34</issue><fpage>4253</fpage><lpage>4258</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.06.022</pub-id><pub-id pub-id-type="pmid">24951864</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Saitoh, Akihiko, and Nobuhiko Okabe. 2014. Recent progress and concerns regarding the Japanese immunization program: Addressing the &#x02018;vaccine gap.&#x02019; <italic>Vaccine</italic> 32 (34): 4253&#x02013;4258. 10.1016/j.vaccine.2014.06.022.<pub-id pub-id-type="pmid">24951864</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>Aya</given-names></name><name><surname>Takaku</surname><given-names>Mayumi</given-names></name><name><surname>Saitoh</surname><given-names>Akihiko</given-names></name></person-group><article-title>High rates of vaccine hesitancy among pregnant women during the coronavirus disease 2019 (COVID-19) pandemic in Japan</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2022</year><volume>18</volume><issue>5</issue><fpage>2064686</fpage><pub-id pub-id-type="doi">10.1080/21645515.2022.2064686</pub-id><pub-id pub-id-type="pmid">35476032</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Saitoh, Aya, Mayumi Takaku, and Akihiko Saitoh. 2022. High rates of vaccine hesitancy among pregnant women during the coronavirus disease 2019 (COVID-19) pandemic in Japan. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 18 (5): 2064686. 10.1080/21645515.2022.2064686.<pub-id pub-id-type="pmid">35476032</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><mixed-citation publication-type="other">Savulescu, Julian. 2023. Ethics of selective restriction of liberty in a pandemic. In <italic>Pandemic ethics: From COVID-19 to disease X</italic>, ed. Julian Savulescu and Dominic Wilkinson. Oxford (UK): Oxford University Press. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/37343117">https://www.ncbi.nlm.nih.gov/pubmed/37343117</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR71"><mixed-citation publication-type="other">Savulescu, Julian, Alberto Giubilini, and Margie Danchin. 2021. Global ethical considerations regarding mandatory vaccination in children. <italic>Journal of Pediatrics</italic> 231:10&#x02013;16. 10.1016/j.jpeds.2021.01.021.</mixed-citation></ref><ref id="CR72"><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Kazuki</given-names></name><name><surname>Sorano</surname><given-names>Sumire</given-names></name><name><surname>Iwai</surname><given-names>Kenji</given-names></name></person-group><article-title>Vaccine hesitancy in Japan: Is the country well prepared for Tokyo 2020?</article-title><source>Travel Medicine and Infectious Disease</source><year>2020</year><volume>34</volume><issue>101609</issue><fpage>101609</fpage><pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101609</pub-id><pub-id pub-id-type="pmid">32112858</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Shimizu, Kazuki, Sumire Sorano, and Kenji Iwai. 2020. Vaccine hesitancy in Japan: Is the country well prepared for Tokyo 2020? <italic>Travel Medicine and Infectious Disease</italic> 34 (101609): 101609. 10.1016/j.tmaid.2020.101609.<pub-id pub-id-type="pmid">32112858</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname><given-names>Kate T</given-names></name><name><surname>Hanley</surname><given-names>Sharon J. B</given-names></name><name><surname>Smith</surname><given-names>Megan A</given-names></name><name><surname>Keane</surname><given-names>Adam</given-names></name><name><surname>Canfell</surname><given-names>Karen</given-names></name></person-group><article-title>Impact of HPV vaccine hesitancy on cervical cancer in Japan: A modelling study</article-title><source>Lancet Public Health</source><year>2020</year><volume>5</volume><issue>4</issue><fpage>e223</fpage><lpage>e234</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(20)30010-4</pub-id><pub-id pub-id-type="pmid">32057317</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Simms, Kate T., Sharon J. B. Hanley, Megan A. Smith, Adam Keane, and Karen Canfell. 2020. Impact of HPV vaccine hesitancy on cervical cancer in Japan: A modelling study. <italic>Lancet Public Health</italic> 5 (4): e223&#x02013;e234. 10.1016/S2468-2667(20)30010-4.<pub-id pub-id-type="pmid">32057317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><mixed-citation publication-type="other">Soares, Patricia, Jo&#x000e3;o Victor Rocha, Marta Moniz, Ana Gama, Pedro Almeida Laires, Ana Rita Pedro, S&#x000f3;nia Dias, Andreia Leite, and Carla Nunes. 2021. Factors associated with COVID-19 vaccine hesitancy. <italic>Vaccines</italic> 9 (3): 300. 10.3390/vaccines9030300.</mixed-citation></ref><ref id="CR75"><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Zhaohui</given-names></name><name><surname>McDonnell</surname><given-names>Dean</given-names></name><name><surname>Cheshmehzangi</surname><given-names>Ali</given-names></name><name><surname>Li</surname><given-names>Xiaoshan</given-names></name><name><surname>Maestro</surname><given-names>Daniel</given-names></name><name><surname>&#x00160;egalo</surname><given-names>Sabina</given-names></name><name><surname>Ahmad</surname><given-names>Junaid</given-names></name><name><surname>Hao</surname><given-names>Xiaoning</given-names></name></person-group><article-title>With great hopes come great expectations: Access and adoption issues associated with COVID-19 vaccines</article-title><source>JMIR Public Health and Surveillance</source><year>2021</year><volume>7</volume><issue>8</issue><fpage>e26111</fpage><pub-id pub-id-type="doi">10.2196/26111</pub-id><pub-id pub-id-type="pmid">33560997</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Su, Zhaohui, Dean McDonnell, Ali Cheshmehzangi, Xiaoshan Li, Daniel Maestro, Sabina &#x00160;egalo, Junaid Ahmad, and Xiaoning Hao. 2021. With great hopes come great expectations: Access and adoption issues associated with COVID-19 vaccines. <italic>JMIR Public Health and Surveillance</italic> 7 (8): e26111. 10.2196/26111.<pub-id pub-id-type="pmid">33560997</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><mixed-citation publication-type="other">Sugawara, Norio, Norio Yasui-Furukori, Atsuhito Fukushima, and Kazutaka Shimoda. 2021. Attitudes of medical students toward COVID-19 vaccination: Who is willing to receive a third dose of the vaccine? <italic>Vaccines</italic> 9 (11): 1295. 10.3390/vaccines9111295.</mixed-citation></ref><ref id="CR77"><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Sukhera</surname><given-names>Javeed</given-names></name></person-group><article-title>Narrative reviews: Flexible, rigorous, and practical</article-title><source>Journal of Graduate Medical Education</source><year>2022</year><volume>14</volume><issue>4</issue><fpage>414</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.4300/JGME-D-22-00480.1</pub-id><pub-id pub-id-type="pmid">35991099</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Sukhera, Javeed. 2022. Narrative reviews: Flexible, rigorous, and practical. <italic>Journal of Graduate Medical Education</italic> 14 (4): 414&#x02013;417. 10.4300/JGME-D-22-00480.1.<pub-id pub-id-type="pmid">35991099</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><mixed-citation publication-type="other">Suzuki, Naho, Tetsuya Yamamoto, Chigusa Uchiumi, and Nagisa Sugaya. 2022. Socio-economic and behavioral characteristics associated with COVID-19 vaccine hesitancy under a declared state of emergency in Japan. <italic>Brain, Behavior, &#x00026; Immunity - Health</italic> 22:100448. 10.1016/j.bbih.2022.100448.</mixed-citation></ref><ref id="CR79"><mixed-citation publication-type="other">Takahashi, Shuko, Naomi Takahashi, Satoshi Sasaki, Masaru Nohara, and Ichiro Kawachi. 2022a. Occupational disparities in COVID-19 vaccine hesitancy in Japan. <italic>SSM - Population Health</italic> 19:101226. 10.1016/j.ssmph.2022.101226.</mixed-citation></ref><ref id="CR80"><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Yoko</given-names></name><name><surname>Ishitsuka</surname><given-names>Kazue</given-names></name><name><surname>Sampei</surname><given-names>Makiko</given-names></name><name><surname>Okawa</surname><given-names>Sumiyo</given-names></name><name><surname>Hosokawa</surname><given-names>Yoshihiko</given-names></name><name><surname>Ishiguro</surname><given-names>Akira</given-names></name><name><surname>Tabuchi</surname><given-names>Takahiro</given-names></name><name><surname>Morisaki</surname><given-names>Naho</given-names></name></person-group><article-title>COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><issue>47</issue><fpage>6849</fpage><lpage>6856</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.09.094</pub-id><pub-id pub-id-type="pmid">36266127</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Takahashi, Yoko, Kazue Ishitsuka, Makiko Sampei, Sumiyo Okawa, Yoshihiko Hosokawa, Akira Ishiguro, Takahiro Tabuchi, and Naho Morisaki. 2022b. COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan. <italic>Vaccine</italic> 40 (47): 6849&#x02013;6856. 10.1016/j.vaccine.2022.09.094.<pub-id pub-id-type="pmid">36266127</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><mixed-citation publication-type="other">Tanaka, Hirokazu, Takahiro Tabuchi, and Kota Katanoda. 2023. Prevalence of COVID-19 vaccination and approval rating of the social implementation of its certification: the Japan COVID-19 and Society Internet Survey (JACSIS) in September and October 2021. <italic>&#x065e5;&#x0672c;&#x0516c;&#x08846;&#x0885b;&#x0751f;&#x096d1;&#x08a8c;</italic> 70 (3): 171&#x02013;184. <ext-link ext-link-type="uri" xlink:href="https://www.jstage.jst.go.jp/article/jph/advpub/0/advpub_22-061/_article/-char/ja/">https://www.jstage.jst.go.jp/article/jph/advpub/0/advpub_22-061/_article/-char/ja/</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR82"><mixed-citation publication-type="other">Tokiya, Mikiko, Megumi Hara, Akiko Matsumoto, Mohammad Said Ashenagar, Takashi Nakano, and Yoshio Hirota. 2022a. Association of vaccine confidence and hesitancy in three phases of COVID-19 vaccine approval and introduction in Japan. <italic>Vaccines</italic> 10 (3): 423. 10.3390/vaccines10030423.</mixed-citation></ref><ref id="CR83"><mixed-citation publication-type="other">Tokiya, Mikiko, Megumi Hara, Akiko Matsumoto, Mohammad Said Ashenagar, Takashi Nakano, and Yoshio Hirota. 2022b. Acceptance of booster COVID-19 vaccine and its association with components of vaccination readiness in the general population: A cross-sectional survey for starting booster dose in Japan. <italic>Vaccines</italic> 10 (7): 1102. 10.3390/vaccines10071102.</mixed-citation></ref><ref id="CR84"><mixed-citation publication-type="other">Tucker, John. 2022. Japanese confucian philosophy. In <italic>The Stanford encyclopedia of philosophy</italic>, ed. Edward N. Zalta and Uri Nodelman, Winter 2022. Metaphysics Research Lab, Stanford University. <ext-link ext-link-type="uri" xlink:href="https://plato.stanford.edu/archives/win2022/entries/japanese-confucian/">https://plato.stanford.edu/archives/win2022/entries/japanese-confucian/</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR85"><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>Makoto</given-names></name><name><surname>Fujita</surname><given-names>Sumio</given-names></name><name><surname>Shimizu</surname><given-names>Nobuyuki</given-names></name><name><surname>Liew</surname><given-names>Kongmeng</given-names></name><name><surname>Wakamiya</surname><given-names>Shoko</given-names></name><name><surname>Aramaki</surname><given-names>Eiji</given-names></name></person-group><article-title>Measuring concerns about the COVID-19 vaccine among Japanese internet users through search queries</article-title><source>Scientific Reports</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>15037</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-18307-4</pub-id><pub-id pub-id-type="pmid">36057657</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Uehara, Makoto, Sumio Fujita, Nobuyuki Shimizu, Kongmeng Liew, Shoko Wakamiya, and Eiji Aramaki. 2022. Measuring concerns about the COVID-19 vaccine among Japanese internet users through search queries. <italic>Scientific Reports</italic> 12 (1): 15037. 10.1038/s41598-022-18307-4.<pub-id pub-id-type="pmid">36057657</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><mixed-citation publication-type="other">Ujiie, Mugen. 2019. Rubella resurgence in Japan 2018&#x02013;2019. <italic>Journal of Travel Medicine</italic> 26 (6): taz047. 10.1093/jtm/taz047.</mixed-citation></ref><ref id="CR87"><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Ujiie</surname><given-names>Mugen</given-names></name><name><surname>Kitano</surname><given-names>Taito</given-names></name><name><surname>Tsuzuki</surname><given-names>Shinya</given-names></name></person-group><article-title>Changing trends in HPV vaccination in Japan</article-title><source>Human Vaccines &#x00026; Immunotherapeutics</source><year>2022</year><volume>18</volume><issue>1</issue><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1080/21645515.2021.1986333</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Ujiie, Mugen, Taito Kitano, and Shinya Tsuzuki. 2022. Changing trends in HPV vaccination in Japan. <italic>Human Vaccines &#x00026; Immunotherapeutics</italic> 18 (1): 1&#x02013;3. 10.1080/21645515.2021.1986333.</mixed-citation></citation-alternatives></ref><ref id="CR88"><mixed-citation publication-type="other">WHO. 2019. Ten Threats to Global Health in 2019. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019">https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR89"><mixed-citation publication-type="other">Wingfield-Hayes, Rupert. 2021. Japan: From vaccine hesitancy to vaccine success. <italic>BBC</italic>, 20 November 2021. <ext-link ext-link-type="uri" xlink:href="https://www.bbc.com/news/world-asia-59342308">https://www.bbc.com/news/world-asia-59342308</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR90"><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>Li Ping</given-names></name><name><surname>Alias</surname><given-names>Haridah</given-names></name><name><surname>Danaee</surname><given-names>Mahmoud</given-names></name><name><surname>Ahmed</surname><given-names>Jamil</given-names></name><name><surname>Lachyan</surname><given-names>Abhishek</given-names></name><name><surname>Cai</surname><given-names>Carla Zi</given-names></name><name><surname>Lin</surname><given-names>Yulan</given-names></name><etal/></person-group><article-title>COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: A global survey of 17 countries</article-title><source>Infectious Diseases of Poverty</source><year>2021</year><volume>10</volume><issue>1</issue><fpage>122</fpage><pub-id pub-id-type="doi">10.1186/s40249-021-00900-w</pub-id><pub-id pub-id-type="pmid">34620243</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Wong, Li Ping, Haridah Alias, Mahmoud Danaee, Jamil Ahmed, Abhishek Lachyan, Carla Zi Cai, Yulan Lin, et al. 2021. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: A global survey of 17 countries. <italic>Infectious Diseases of Poverty</italic> 10 (1): 122. 10.1186/s40249-021-00900-w.<pub-id pub-id-type="pmid">34620243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><mixed-citation publication-type="other">World Health Organization. 2022. COVID-19 and Mandatory Vaccination: Ethical Considerations. <italic>World Health Organization</italic>, 30 May 2022. <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/354585/WHO-2019-nCoV-Policy-brief-Mandatory-vaccination-2022.1-eng.pdf?sequence=1">https://iris.who.int/bitstream/handle/10665/354585/WHO-2019-nCoV-Policy-brief-Mandatory-vaccination-2022.1-eng.pdf?sequence=1</ext-link>. Accessed 14 June 2024.</mixed-citation></ref><ref id="CR92"><mixed-citation publication-type="other">Yoda, Takeshi, and Hironobu Katsuyama. 2021. Willingness to receive COVID-19 vaccination in Japan. <italic>Vaccines</italic> 9 (1): 48. 10.3390/vaccines9010048.</mixed-citation></ref><ref id="CR93"><mixed-citation publication-type="other">Yoda, Takeshi, Benjamas Suksatit, Masaaki Tokuda, and Hironobu Katsuyama. 2022. The relationship between sources of COVID-19 vaccine information and willingness to be vaccinated: An internet-based cross-sectional study in Japan. <italic>Vaccines</italic> 10 (7): 1041. 10.3390/vaccines10071041.</mixed-citation></ref><ref id="CR94"><mixed-citation publication-type="other">Yoneoka, Daisuke, Akifumi Eguchi, Shuhei Nomura, Takayuki Kawashima, Yuta Tanoue, Michio Murakami, Haruka Sakamoto, et al. 2022. Identification of optimum combinations of media channels for approaching COVID-19 vaccine unsure and unwilling groups in Japan. <italic>Lancet Regional Health. Western Pacific</italic> 18:100330. 10.1016/j.lanwpc.2021.100330.</mixed-citation></ref><ref id="CR95"><mixed-citation publication-type="other">Yoshizaki, Y. 1997. The value shift of Japanese youth. <italic>Comparative Civilizations Review</italic> 35: 2. <ext-link ext-link-type="uri" xlink:href="https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=1379&#x00026;context=ccr">https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=1379&#x00026;context=ccr</ext-link>. Accessed 14 June 2024.</mixed-citation></ref></ref-list></back></article>